{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cannabis plant", "cannabinoid receptors", "endocannabinoids", "inflammation.", "phytocannabinoid", "terpenoids"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32235333", "DateCompleted": {"Year": "2020", "Month": "12", "Day": "28"}, "DateRevised": {"Year": "2024", "Month": "08", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "03", "Day": "29"}], "Language": ["eng"], "ELocationID": ["1567", "10.3390/molecules25071567"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "25", "Issue": "7", "PubDate": {"Year": "2020", "Month": "Mar", "Day": "29"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Terpenoids, Cannabimimetic Ligands, beyond the <i>Cannabis</i> Plant.", "Abstract": {"AbstractText": ["Medicinal use of <i>Cannabis sativa</i> L. has an extensive history and it was essential in the discovery of phytocannabinoids, including the <i>Cannabis</i> major psychoactive compound-\u03949-tetrahydrocannabinol (\u03949-THC)-as well as the G-protein-coupled cannabinoid receptors (CBR), named cannabinoid receptor type-1 (CB1R) and cannabinoid receptor type-2 (CB2R), both part of the now known endocannabinoid system (ECS). Cannabinoids is a vast term that defines several compounds that have been characterized in three categories: (i) endogenous, (ii) synthetic, and (iii) phytocannabinoids, and are able to modulate the CBR and ECS. Particularly, phytocannabinoids are natural terpenoids or phenolic compounds derived from <i>Cannabis sativa</i>. However, these terpenoids and phenolic compounds can also be derived from other plants (non-cannabinoids) and still induce cannabinoid-like properties. Cannabimimetic ligands, beyond the <i>Cannabis</i> plant, can act as CBR agonists or antagonists, or ECS enzyme inhibitors, besides being able of playing a role in immune-mediated inflammatory and infectious diseases, neuroinflammatory, neurological, and neurodegenerative diseases, as well as in cancer, and autoimmunity by itself. In this review, we summarize and critically highlight past, present, and future progress on the understanding of the role of cannabinoid-like molecules, mainly terpenes, as prospective therapeutics for different pathological conditions."]}, "AuthorList": [{"Identifier": ["0000-0003-0682-3019"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Autoimmunity and Immunopharmacology (LAIF), Department of Health Sciences, Campus Ararangu\u00e1, Universidade Federal de Santa Catarina, Ararangu\u00e1 88906-072, Brazil."}, {"Identifier": [], "Affiliation": "Graduate Program of Neuroscience, Center of Biological Sciences, Campus Florian\u00f3polis, Universidade Federal de Santa Catarina, Florian\u00f3polis 88040-900, Brazil."}], "LastName": "Gon\u00e7alves", "ForeName": "Elaine C D", "Initials": "ECD"}, {"Identifier": ["0000-0002-6254-2812"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Autoimmunity and Immunopharmacology (LAIF), Department of Health Sciences, Campus Ararangu\u00e1, Universidade Federal de Santa Catarina, Ararangu\u00e1 88906-072, Brazil."}], "LastName": "Baldasso", "ForeName": "Gabriela M", "Initials": "GM"}, {"Identifier": ["0000-0002-3648-8824"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neurosurgery Department, Neurosurgery Pain Research institute, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA."}], "LastName": "Bicca", "ForeName": "Ma\u00edra A", "Initials": "MA"}, {"Identifier": ["0000-0002-2330-4862"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Autoimmunity and Immunopharmacology (LAIF), Department of Health Sciences, Campus Ararangu\u00e1, Universidade Federal de Santa Catarina, Ararangu\u00e1 88906-072, Brazil."}], "LastName": "Paes", "ForeName": "Rodrigo S", "Initials": "RS"}, {"Identifier": ["0000-0002-3335-1822"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Agricultural Sciences, University of Naples Federico II, 80,055 Portici, Italy."}], "LastName": "Capasso", "ForeName": "Raffaele", "Initials": "R"}, {"Identifier": ["0000-0002-6938-2161"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Autoimmunity and Immunopharmacology (LAIF), Department of Health Sciences, Campus Ararangu\u00e1, Universidade Federal de Santa Catarina, Ararangu\u00e1 88906-072, Brazil."}, {"Identifier": [], "Affiliation": "Graduate Program of Neuroscience, Center of Biological Sciences, Campus Florian\u00f3polis, Universidade Federal de Santa Catarina, Florian\u00f3polis 88040-900, Brazil."}], "LastName": "Dutra", "ForeName": "Rafael C", "Initials": "RC"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Bicyclic Monoterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Cannabinoid Receptor Agonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Nootropic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Terpenes"}, {"RegistryNumber": "11029-06-4", "NameOfSubstance": "elemene"}, {"RegistryNumber": "19GBJ60SN5", "NameOfSubstance": "Cannabidiol"}, {"RegistryNumber": "7J8897W37S", "NameOfSubstance": "Dronabinol"}, {"RegistryNumber": "G3VG94Z26E", "NameOfSubstance": "camphene"}, {"RegistryNumber": "JPF3YI7O34", "NameOfSubstance": "alpha-pinene"}], "MeshHeadingList": [{"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Anxiety"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Bicyclic Monoterpenes"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Cannabidiol"}, {"QualifierName": ["chemistry", "classification", "isolation & purification", "pharmacology"], "DescriptorName": "Cannabinoid Receptor Agonists"}, {"QualifierName": ["chemistry"], "DescriptorName": "Cannabis"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Cognitive Dysfunction"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Dronabinol"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Inflammatory Bowel Diseases"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Neuralgia"}, {"QualifierName": ["chemistry", "classification", "isolation & purification", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["chemistry", "classification", "isolation & purification", "pharmacology"], "DescriptorName": "Nootropic Agents"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Schizophrenia"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Terpenes"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Di Marzo V., Bifulco M., De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat. Reviews. Drug Discov. 2004;3:771\u2013784. doi: 10.1038/nrd1495.", "ArticleIdList": ["10.1038/nrd1495", "15340387"]}, {"Citation": "Rubin V. Cannabis and Culture. Mouton; The Hague, The Netherlands: 1975."}, {"Citation": "Guy G.W., Whittle B.A., Robson P. The Medicinal Uses of Cannabis and Cannabinoids. Pharmaceutical Press; London, UK: 2004."}, {"Citation": "Pacher P., Batkai S., Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 2006;58:389\u2013462. doi: 10.1124/pr.58.3.2.", "ArticleIdList": ["10.1124/pr.58.3.2", "PMC2241751", "16968947"]}, {"Citation": "Russell C., Rueda S., Room R., Tyndall M., Fischer B. Routes of administration for cannabis use\u2014Basic prevalence and related health outcomes: A scoping review and synthesis. Int. J. Drug Policy. 2018;52:87\u201396. doi: 10.1016/j.drugpo.2017.11.008.", "ArticleIdList": ["10.1016/j.drugpo.2017.11.008", "29277082"]}, {"Citation": "Azofeifa A., Mattson M.E., Schauer G., McAfee T., Grant A., Lyerla R. National Estimates of Marijuana Use and Related Indicators\u2014National Survey on Drug Use and Health, United States, 2002\u20132014. Morb. Mortal. Wkly. Rep. Surveill. Summ. 2016;65:1\u201328. doi: 10.15585/mmwr.ss6511a1.", "ArticleIdList": ["10.15585/mmwr.ss6511a1", "27584586"]}, {"Citation": "Degenhardt L., Ferrari A.J., Calabria B., Hall W.D., Norman R.E., McGrath J., Flaxman A.D., Engell R.E., Freedman G.D., Whiteford H.A., et al. The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: Results from the GBD 2010 study. PLoS ONE. 2013;8:e76635. doi: 10.1371/journal.pone.0076635.", "ArticleIdList": ["10.1371/journal.pone.0076635", "PMC3811989", "24204649"]}, {"Citation": "Hasin D.S., Saha T.D., Kerridge B.T., Goldstein R.B., Chou S.P., Zhang H., Jung J., Pickering R.P., Ruan W.J., Smith S.M., et al. Prevalence of Marijuana Use Disorders in the United States between 2001\u20132002 and 2012\u20132013. JAMA Psychiatry. 2015;72:1235\u20131242. doi: 10.1001/jamapsychiatry.2015.1858.", "ArticleIdList": ["10.1001/jamapsychiatry.2015.1858", "PMC5037576", "26502112"]}, {"Citation": "Hasin D.S., Sarvet A.L., Cerda M., Keyes K.M., Stohl M., Galea S., Wall M.M. US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991\u20131992 to 2012\u20132013. JAMA Psychiatry. 2017;74:579\u2013588. doi: 10.1001/jamapsychiatry.2017.0724.", "ArticleIdList": ["10.1001/jamapsychiatry.2017.0724", "PMC5539836", "28445557"]}, {"Citation": "Han B., Compton W.M., Blanco C., Jones C.M. Trends in and correlates of medical marijuana use among adults in the United States. Drug Alcohol Depend. 2018;186:120\u2013129. doi: 10.1016/j.drugalcdep.2018.01.022.", "ArticleIdList": ["10.1016/j.drugalcdep.2018.01.022", "29567626"]}, {"Citation": "Han B., Compton W.M., Jones C.M., Blanco C. Cannabis Use and Cannabis Use Disorders among Youth in the United States, 2002\u20132014. J. Clin. Psychiatry. 2017;78:1404\u20131413. doi: 10.4088/JCP.16m10948.", "ArticleIdList": ["10.4088/JCP.16m10948", "PMC6984758", "28686820"]}, {"Citation": "Hill K.P. Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders. JAMA. 2017;317:1070\u20131071. doi: 10.1001/jama.2016.19706.", "ArticleIdList": ["10.1001/jama.2016.19706", "28291877"]}, {"Citation": "Belackova V., Stefunkova M. Interpreting the Czech drug decriminalization: The glass is half full\u2014Response to Cerveny, J., Chomynova, P., Mravcik, V., & van Ours, J.C. (2017). Cannabis decriminalization and the age of onset of cannabis use. Int. J. Drug Policy. 2018;52:102\u2013105.", "ArticleIdList": ["29414461"]}, {"Citation": "Belackova V., Wilkins C. Consumer agency in cannabis supply\u2014Exploring auto-regulatory documents of the cannabis social clubs in Spain. Int. J. Drug Policy. 2018;54:26\u201334. doi: 10.1016/j.drugpo.2017.12.018.", "ArticleIdList": ["10.1016/j.drugpo.2017.12.018", "29367012"]}, {"Citation": "Room R. Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond. Addiction. 2014;109:345\u2013351. doi: 10.1111/add.12355.", "ArticleIdList": ["10.1111/add.12355", "24180513"]}, {"Citation": "Room R. Cannabis legalization and public health: Legal niceties, commercialization and countercultures. Addiction. 2014;109:358\u2013359. doi: 10.1111/add.12481.", "ArticleIdList": ["10.1111/add.12481", "24524317"]}, {"Citation": "Wilkinson S.T., D\u2019Souza D.C. Problems with the medicalization of marijuana. JAMA. 2014;311:2377\u20132378. doi: 10.1001/jama.2014.6175.", "ArticleIdList": ["10.1001/jama.2014.6175", "PMC6248328", "24845238"]}, {"Citation": "Devane W.A., Dysarz F.A., 3rd, Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 1988;34:605\u2013613.", "ArticleIdList": ["2848184"]}, {"Citation": "Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561\u2013564. doi: 10.1038/346561a0.", "ArticleIdList": ["10.1038/346561a0", "2165569"]}, {"Citation": "ElSohly M.A., Radwan M.M., Gul W., Chandra S., Galal A. Phytochemistry of Cannabis sativa L. Prog. Chem. Org. Nat. Prod. 2017;103:1\u201336.", "ArticleIdList": ["28120229"]}, {"Citation": "Russo E., Guy G.W. A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med. Hypotheses. 2006;66:234\u2013246. doi: 10.1016/j.mehy.2005.08.026.", "ArticleIdList": ["10.1016/j.mehy.2005.08.026", "16209908"]}, {"Citation": "Esposito G., Scuderi C., Valenza M., Togna G.I., Latina V., De Filippis D., Cipriano M., Carratu M.R., Iuvone T., Steardo L. Cannabidiol reduces Abeta-induced neuroinflammation and promotes hippocampal neurogenesis through PPARgamma involvement. PLoS ONE. 2011;6:e28668. doi: 10.1371/journal.pone.0028668.", "ArticleIdList": ["10.1371/journal.pone.0028668", "PMC3230631", "22163051"]}, {"Citation": "Martin-Moreno A.M., Reigada D., Ramirez B.G., Mechoulam R., Innamorato N., Cuadrado A., de Ceballos M.L. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: Relevance to Alzheimer\u2019s disease. Mol. Pharmacol. 2011;79:964\u2013973. doi: 10.1124/mol.111.071290.", "ArticleIdList": ["10.1124/mol.111.071290", "PMC3102548", "21350020"]}, {"Citation": "Mecha M., Torrao A.S., Mestre L., Carrillo-Salinas F.J., Mechoulam R., Guaza C. Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress. Cell Death Dis. 2012;3:e331. doi: 10.1038/cddis.2012.71.", "ArticleIdList": ["10.1038/cddis.2012.71", "PMC3388241", "22739983"]}, {"Citation": "Shannon S., Opila-Lehman J. Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report. Perm. J. 2016;20:16-005. doi: 10.7812/TPP/16-005.", "ArticleIdList": ["10.7812/TPP/16-005", "PMC5101100", "27768570"]}, {"Citation": "Marinho A.L., Vila-Verde C., Fogaca M.V., Guimaraes F.S. Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT(1)A receptors and stressful experiences. Behav. Brain Res. 2015;286:49\u201356. doi: 10.1016/j.bbr.2015.02.023.", "ArticleIdList": ["10.1016/j.bbr.2015.02.023", "25701682"]}, {"Citation": "Jadoon K.A., Ratcliffe S.H., Barrett D.A., Thomas E.L., Stott C., Bell J.D., O\u2019Sullivan S.E., Tan G.D. Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study. Diabetes Care. 2016;39:1777\u20131786. doi: 10.2337/dc16-0650.", "ArticleIdList": ["10.2337/dc16-0650", "27573936"]}, {"Citation": "Dhital S., Stokes J.V., Park N., Seo K.S., Kaplan B.L. Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation. Cell. Immunol. 2017;312:25\u201334. doi: 10.1016/j.cellimm.2016.11.006.", "ArticleIdList": ["10.1016/j.cellimm.2016.11.006", "PMC5327652", "27865421"]}, {"Citation": "Krohn R.M., Parsons S.A., Fichna J., Patel K.D., Yates R.M., Sharkey K.A., Storr M.A. Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment. J. Inflamm. 2016;13:21. doi: 10.1186/s12950-016-0129-0.", "ArticleIdList": ["10.1186/s12950-016-0129-0", "PMC4944257", "27418880"]}, {"Citation": "Norris C., Loureiro M., Kramar C., Zunder J., Renard J., Rushlow W., Laviolette S.R. Cannabidiol Modulates Fear Memory Formation through Interactions with Serotonergic Transmission in the Mesolimbic System. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2016;41:2839\u20132850. doi: 10.1038/npp.2016.93.", "ArticleIdList": ["10.1038/npp.2016.93", "PMC5061893", "27296152"]}, {"Citation": "Genaro K., Fabris D., Arantes A.L.F., Zuardi A.W., Crippa J.A.S., Prado W.A. Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats. Front. Pharmacol. 2017;8:391. doi: 10.3389/fphar.2017.00391.", "ArticleIdList": ["10.3389/fphar.2017.00391", "PMC5478794", "28680401"]}, {"Citation": "Harris H.M., Sufka K.J., Gul W., ElSohly M.A. Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice. Planta Med. 2016;82:1169\u20131172. doi: 10.1055/s-0042-106303.", "ArticleIdList": ["10.1055/s-0042-106303", "27214593"]}, {"Citation": "Peres F.F., Levin R., Suiama M.A., Diana M.C., Gouvea D.A., Almeida V., Santos C.M., Lungato L., Zuardi A.W., Hallak J.E., et al. Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats. Front. Pharmacol. 2016;7:343. doi: 10.3389/fphar.2016.00343.", "ArticleIdList": ["10.3389/fphar.2016.00343", "PMC5040118", "27733830"]}, {"Citation": "Peres F.F., Diana M.C., Suiama M.A., Justi V., Almeida V., Bressan R.A., Zuardi A.W., Hallak J.E., Crippa J.A., Abilio V.C. Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia. Schizophr. Res. 2016;172:220\u2013221. doi: 10.1016/j.schres.2016.02.004.", "ArticleIdList": ["10.1016/j.schres.2016.02.004", "26856781"]}, {"Citation": "Renard J., Loureiro M., Rosen L.G., Zunder J., de Oliveira C., Schmid S., Rushlow W.J., Laviolette S.R. Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway. J. Neurosci. Off. J. Soc. Neurosci. 2016;36:5160\u20135169. doi: 10.1523/JNEUROSCI.3387-15.2016.", "ArticleIdList": ["10.1523/JNEUROSCI.3387-15.2016", "PMC4854973", "27147666"]}, {"Citation": "Devinsky O., Cross J.H., Wright S. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N. Engl. J. Med. 2017;377:699\u2013700. doi: 10.1056/NEJMoa1611618.", "ArticleIdList": ["10.1056/NEJMoa1611618", "28813226"]}, {"Citation": "Hosseinzadeh M., Nikseresht S., Khodagholi F., Naderi N., Maghsoudi N. Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure. J. Mol. Neurosci. MN. 2016;58:432\u2013440. doi: 10.1007/s12031-015-0703-6.", "ArticleIdList": ["10.1007/s12031-015-0703-6", "26738731"]}, {"Citation": "Kaplan E.H., Offermann E.A., Sievers J.W., Comi A.M. Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome. Pediatr. Neurol. 2017;71:18\u201323 e2. doi: 10.1016/j.pediatrneurol.2017.02.009.", "ArticleIdList": ["10.1016/j.pediatrneurol.2017.02.009", "28454984"]}, {"Citation": "Patel R.R., Barbosa C., Brustovetsky T., Brustovetsky N., Cummins T.R. Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol. Pt 8Brain J. Neurol. 2016;139:2164\u20132181. doi: 10.1093/brain/aww129.", "ArticleIdList": ["10.1093/brain/aww129", "PMC4958898", "27267376"]}, {"Citation": "Ibsen M.S., Connor M., Glass M. Cannabinoid CB1 and CB2 Receptor Signaling and Bias. Cannabis Cannabinoid Res. 2017;2:48\u201360. doi: 10.1089/can.2016.0037.", "ArticleIdList": ["10.1089/can.2016.0037", "PMC5436336", "28861504"]}, {"Citation": "McHugh D., Page J., Dunn E., Bradshaw H.B. Delta(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. Br. J. Pharmacol. 2012;165:2414\u20132424. doi: 10.1111/j.1476-5381.2011.01497.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01497.x", "PMC3423258", "21595653"]}, {"Citation": "Pertwee R.G., Howlett A.C., Abood M.E., Alexander S.P., Di Marzo V., Elphick M.R., Greasley P.J., Hansen H.S., Kunos G., Mackie K., et al. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: Beyond CB(1) and CB(2) Pharmacol. Rev. 2010;62:588\u2013631. doi: 10.1124/pr.110.003004.", "ArticleIdList": ["10.1124/pr.110.003004", "PMC2993256", "21079038"]}, {"Citation": "Davis K.D., Flor H., Greely H.T., Iannetti G.D., Mackey S., Ploner M., Pustilnik A., Tracey I., Treede R.D., Wager T.D. Brain imaging tests for chronic pain: Medical, legal and ethical issues and recommendations. Nat. Rev. Neurol. 2017;13:624\u2013638. doi: 10.1038/nrneurol.2017.122.", "ArticleIdList": ["10.1038/nrneurol.2017.122", "28884750"]}, {"Citation": "Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002;54:161\u2013202. doi: 10.1124/pr.54.2.161.", "ArticleIdList": ["10.1124/pr.54.2.161", "12037135"]}, {"Citation": "Ashton J.C., Glass M. The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. Curr. Neuropharmacol. 2007;5:73\u201380. doi: 10.2174/157015907780866884.", "ArticleIdList": ["10.2174/157015907780866884", "PMC2435344", "18615177"]}, {"Citation": "Rom S., Persidsky Y. Cannabinoid receptor 2: Potential role in immunomodulation and neuroinflammation. J. Neuroimmune Pharmacol. Off. J. Soc. Neuroimmune Pharmacol. 2013;8:608\u2013620. doi: 10.1007/s11481-013-9445-9.", "ArticleIdList": ["10.1007/s11481-013-9445-9", "PMC3663904", "23471521"]}, {"Citation": "Pertwee R.G. The pharmacology of cannabinoid receptors and their ligands: An overview. Int. J. Obes. 2006;30(Suppl. 1):S13\u2013S18. doi: 10.1038/sj.ijo.0803272.", "ArticleIdList": ["10.1038/sj.ijo.0803272", "16570099"]}, {"Citation": "Pertwee R.G. Pharmacological actions of cannabinoids. Handb. Exp. Pharmacol. 2005;168:1\u201351. doi: 10.1007/3-540-26573-2_1.", "ArticleIdList": ["10.1007/3-540-26573-2_1", "16596770"]}, {"Citation": "Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258:1946\u20131949. doi: 10.1126/science.1470919.", "ArticleIdList": ["10.1126/science.1470919", "1470919"]}, {"Citation": "Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 1995;50:83\u201390. doi: 10.1016/0006-2952(95)00109-D.", "ArticleIdList": ["10.1016/0006-2952(95)00109-D", "7605349"]}, {"Citation": "Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., Waku K. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 1995;215:89\u201397. doi: 10.1006/bbrc.1995.2437.", "ArticleIdList": ["10.1006/bbrc.1995.2437", "7575630"]}, {"Citation": "Pertwee R.G. Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr. Med. Chem. 2010;17:1360\u20131381. doi: 10.2174/092986710790980050.", "ArticleIdList": ["10.2174/092986710790980050", "PMC3013229", "20166927"]}, {"Citation": "Goncalves E.D., Dutra R.C. Cannabinoid receptors as therapeutic targets for autoimmune diseases: Where do we stand? Drug Discov. Today. 2019;24:1845\u20131853. doi: 10.1016/j.drudis.2019.05.023.", "ArticleIdList": ["10.1016/j.drudis.2019.05.023", "31158514"]}, {"Citation": "Di Iorio G., Lupi M., Sarchione F., Matarazzo I., Santacroce R., Petruccelli F., Martinotti G., Di Giannantonio M. The endocannabinoid system: A putative role in neurodegenerative diseases. Int. J. High Risk Behav. Addict. 2013;2:100\u2013106. doi: 10.5812/ijhrba.9222.", "ArticleIdList": ["10.5812/ijhrba.9222", "PMC4070159", "24971285"]}, {"Citation": "Wolf S.A., Tauber S., Ullrich O. CNS immune surveillance and neuroinflammation: Endocannabinoids keep control. Curr. Pharm. Des. 2008;14:2266\u20132278. doi: 10.2174/138161208785740090.", "ArticleIdList": ["10.2174/138161208785740090", "18781977"]}, {"Citation": "Cabral G.A., Ferreira G.A., Jamerson M.J. Endocannabinoids and the Immune System in Health and Disease. Handb. Exp. Pharmacol. 2015;231:185\u2013211.", "ArticleIdList": ["26408161"]}, {"Citation": "De Laurentiis A., Araujo H.A., Rettori V. Role of the endocannabinoid system in the neuroendocrine responses to inflammation. Curr. Pharm. Des. 2014;20:4697\u20134706. doi: 10.2174/1381612820666140130212957.", "ArticleIdList": ["10.2174/1381612820666140130212957", "24588819"]}, {"Citation": "Pacher P., Steffens S., Hasko G., Schindler T.H., Kunos G. Cardiovascular effects of marijuana and synthetic cannabinoids: The good, the bad, and the ugly. Nat. Re. Cardiol. 2018;15:151\u2013166. doi: 10.1038/nrcardio.2017.130.", "ArticleIdList": ["10.1038/nrcardio.2017.130", "28905873"]}, {"Citation": "Ashton J.C., Smith P.F. Cannabinoids and cardiovascular disease: The outlook for clinical treatments. Curr. Vasc. Pharmacol. 2007;5:175\u2013185. doi: 10.2174/157016107781024109.", "ArticleIdList": ["10.2174/157016107781024109", "17627561"]}, {"Citation": "Ho W.S.V., Kelly M.E.M. Cannabinoids in the Cardiovascular System. Adv. Pharmacol. 2017;80:329\u2013366.", "ArticleIdList": ["28826540"]}, {"Citation": "Wolff V., Jouanjus E. Strokes are possible complications of cannabinoids use. Pt BEpilepsy Behav. EB. 2017;70:355\u2013363. doi: 10.1016/j.yebeh.2017.01.031.", "ArticleIdList": ["10.1016/j.yebeh.2017.01.031", "28237318"]}, {"Citation": "Singh A., Saluja S., Kumar A., Agrawal S., Thind M., Nanda S., Shirani J. Cardiovascular Complications of Marijuana and Related Substances: A Review. Cardiol. Ther. 2018;7:45\u201359. doi: 10.1007/s40119-017-0102-x.", "ArticleIdList": ["10.1007/s40119-017-0102-x", "PMC5986667", "29218644"]}, {"Citation": "Lu Y., Anderson H.D. Cannabinoid signaling in health and disease. Can. J. Physiol. Pharmacol. 2017;95:311\u2013327. doi: 10.1139/cjpp-2016-0346.", "ArticleIdList": ["10.1139/cjpp-2016-0346", "28263083"]}, {"Citation": "Huestis M.A., Boyd S.J., Heishman S.J., Preston K.L., Bonnet D., Le Fur G., Gorelick D.A. Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology. 2007;194:505\u2013515. doi: 10.1007/s00213-007-0861-5.", "ArticleIdList": ["10.1007/s00213-007-0861-5", "PMC2689519", "17619859"]}, {"Citation": "Kumar A., Premoli M., Aria F., Bonini S.A., Maccarinelli G., Gianoncelli A., Memo M., Mastinu A. Cannabimimetic plants: Are they new cannabinoidergic modulators? Planta. 2019;249:1681\u20131694. doi: 10.1007/s00425-019-03138-x.", "ArticleIdList": ["10.1007/s00425-019-03138-x", "30877436"]}, {"Citation": "Solymosi K., Kofalvi A. Cannabis: A Treasure Trove or Pandora\u2019s Box? Mini Rev. Med. Chem. 2017;17:1223\u20131291. doi: 10.2174/1389557516666161004162133.", "ArticleIdList": ["10.2174/1389557516666161004162133", "27719666"]}, {"Citation": "Morales P., Hurst D.P., Reggio P.H. Molecular Targets of the Phytocannabinoids: A Complex Picture. Prog. Chem. Org. Nat. Prod. 2017;103:103\u2013131.", "ArticleIdList": ["PMC5345356", "28120232"]}, {"Citation": "Campos A.C., Fogaca M.V., Sonego A.B., Guimaraes F.S. Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacol. Res. 2016;112:119\u2013127. doi: 10.1016/j.phrs.2016.01.033.", "ArticleIdList": ["10.1016/j.phrs.2016.01.033", "26845349"]}, {"Citation": "Crivelaro do Nascimento G., Ferrari D.P., Guimaraes F.S., Del Bel E.A., Bortolanza M., Ferreira-Junior N.C. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson\u2019s disease. Neuropharmacology. 2020;163:107808. doi: 10.1016/j.neuropharm.2019.107808.", "ArticleIdList": ["10.1016/j.neuropharm.2019.107808", "31706993"]}, {"Citation": "Mammana S., Cavalli E., Gugliandolo A., Silvestro S., Pollastro F., Bramanti P., Mazzon E. Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol. Medicina. 2019;55:747. doi: 10.3390/medicina55110747.", "ArticleIdList": ["10.3390/medicina55110747", "PMC6915685", "31752240"]}, {"Citation": "Russo E.B., Marcu J. Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads. Adv. Pharmacol. 2017;80:67\u2013134.", "ArticleIdList": ["28826544"]}, {"Citation": "Borrelli F., Pagano E., Romano B., Panzera S., Maiello F., Coppola D., De Petrocellis L., Buono L., Orlando P., Izzo A.A. Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid. Carcinogenesis. 2014;35:2787\u20132797. doi: 10.1093/carcin/bgu205.", "ArticleIdList": ["10.1093/carcin/bgu205", "25269802"]}, {"Citation": "Udoh M., Santiago M., Devenish S., McGregor I.S., Connor M. Cannabichromene is a cannabinoid CB2 receptor agonist. Br. J. Pharmacol. 2019;176:4537\u20134547. doi: 10.1111/bph.14815.", "ArticleIdList": ["10.1111/bph.14815", "PMC6932936", "31368508"]}, {"Citation": "Wilkinson J.D., Williamson E.M. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. J. Dermatol. Sci. 2007;45:87\u201392. doi: 10.1016/j.jdermsci.2006.10.009.", "ArticleIdList": ["10.1016/j.jdermsci.2006.10.009", "17157480"]}, {"Citation": "Al-Ghezi Z.Z., Miranda K., Nagarkatti M., Nagarkatti P.S. Combination of Cannabinoids, Delta9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways. Front. Immunol. 2019;10:1921. doi: 10.3389/fimmu.2019.01921.", "ArticleIdList": ["10.3389/fimmu.2019.01921", "PMC6712515", "31497013"]}, {"Citation": "Haupts M., Vila C., Jonas A., Witte K., Alvarez-Ossorio L. Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity. Eur. Neurol. 2016;75:236\u2013243. doi: 10.1159/000445943.", "ArticleIdList": ["10.1159/000445943", "27160412"]}, {"Citation": "Laprairie R.B., Bagher A.M., Kelly M.E., Denovan-Wright E.M. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br. J. Pharmacol. 2015;172:4790\u20134805. doi: 10.1111/bph.13250.", "ArticleIdList": ["10.1111/bph.13250", "PMC4621983", "26218440"]}, {"Citation": "Blasco-Benito S., Seijo-Vila M., Caro-Villalobos M., Tundidor I., Andradas C., Garcia-Taboada E., Wade J., Smith S., Guzman M., Perez-Gomez E., et al. Appraising the \u201centourage effect\u201d: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. Biochem. Pharmacol. 2018;157:285\u2013293. doi: 10.1016/j.bcp.2018.06.025.", "ArticleIdList": ["10.1016/j.bcp.2018.06.025", "29940172"]}, {"Citation": "Russo E.B. The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No \u201cStrain,\u201d No Gain. Front. Plant Sci. 2018;9:1969. doi: 10.3389/fpls.2018.01969.", "ArticleIdList": ["10.3389/fpls.2018.01969", "PMC6334252", "30687364"]}, {"Citation": "Felipe C.F.B., Albuquerque A.M.S., de Pontes J.L.X., de Melo J.I.V., Rodrigues T., de Sousa A.M.P., Monteiro A.B., Ribeiro A., Lopes J.P., de Menezes I.R.A., et al. Comparative study of alpha- and beta-pinene effect on PTZ-induced convulsions in mice. Fundam. Clin. Pharmacol. 2019;33:181\u2013190. doi: 10.1111/fcp.12416.", "ArticleIdList": ["10.1111/fcp.12416", "30230028"]}, {"Citation": "Zamyad M., Abbasnejad M., Esmaeili-Mahani S., Mostafavi A., Sheibani V. The anticonvulsant effects of Ducrosia anethifolia (Boiss) essential oil are produced by its main component alpha-pinene in rats. Arq. De Neuro-Psiquiatr. 2019;77:106\u2013114. doi: 10.1590/0004-282x20180147.", "ArticleIdList": ["10.1590/0004-282x20180147", "30810595"]}, {"Citation": "Khoshnazar M., Bigdeli M.R., Parvardeh S., Pouriran R. Attenuating effect of alpha-pinene on neurobehavioural deficit, oxidative damage and inflammatory response following focal ischaemic stroke in rat. J. Pharm. Pharmacol. 2019;71:1725\u20131733. doi: 10.1111/jphp.13164.", "ArticleIdList": ["10.1111/jphp.13164", "31523814"]}, {"Citation": "Zhao Y., Chen R., Wang Y., Yang Y. alpha-Pinene Inhibits Human Prostate Cancer Growth in a Mouse Xenograft Model. Chemotherapy. 2018;63:1\u20137. doi: 10.1159/000479863.", "ArticleIdList": ["10.1159/000479863", "29069647"]}, {"Citation": "Araujo-Filho H.G., Pereira E.W.M., Rezende M.M., Menezes P.P., Araujo A.A.S., Barreto R.S.S., Martins A., Albuquerque T.R., Silva B.A.F., Alcantara I.S., et al. D-limonene exhibits superior antihyperalgesic effects in a beta-cyclodextrin-complexed form in chronic musculoskeletal pain reducing Fos protein expression on spinal cord in mice. Neuroscience. 2017;358:158\u2013169. doi: 10.1016/j.neuroscience.2017.06.037.", "ArticleIdList": ["10.1016/j.neuroscience.2017.06.037", "28673718"]}, {"Citation": "Booth J.K., Page J.E., Bohlmann J. Terpene synthases from Cannabis sativa. PLoS ONE. 2017;12:e0173911. doi: 10.1371/journal.pone.0173911.", "ArticleIdList": ["10.1371/journal.pone.0173911", "PMC5371325", "28355238"]}, {"Citation": "Naz S., Hanif M.A., Ansari T.M., Al-Sabahi J.N. A Comparative Study on Hemp (Cannabis sativa) Essential Oil Extraction Using Traditional and Advanced Techniques. Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu. 2017;37:306\u2013311.", "ArticleIdList": ["30221908"]}, {"Citation": "Fidyt K., Fiedorowicz A., Strzadala L., Szumny A. beta-caryophyllene and beta-caryophyllene oxide-natural compounds of anticancer and analgesic properties. Cancer Med. 2016;5:3007\u20133017. doi: 10.1002/cam4.816.", "ArticleIdList": ["10.1002/cam4.816", "PMC5083753", "27696789"]}, {"Citation": "Sabulal B., Dan M., J A.J., Kurup R., Pradeep N.S., Valsamma R.K., George V. Caryophyllene-rich rhizome oil of Zingiber nimmonii from South India: Chemical characterization and antimicrobial activity. Phytochemistry. 2006;67:2469\u20132473. doi: 10.1016/j.phytochem.2006.08.003.", "ArticleIdList": ["10.1016/j.phytochem.2006.08.003", "16973189"]}, {"Citation": "Su Y.C., Ho C.L. Composition of the Leaf Essential Oil of Phoebe formosana from Taiwan and its in vitro Cytotoxic, Antibacterial, and Antifungal Activities. Nat. Prod. Commun. 2016;11:845\u2013848. doi: 10.1177/1934578X1601100637.", "ArticleIdList": ["10.1177/1934578X1601100637", "27534132"]}, {"Citation": "Sarvmeili N., Jafarian-Dehkordi A., Zolfaghari B. Cytotoxic effects of Pinus eldarica essential oil and extracts on HeLa and MCF-7 cell lines. Res. Pharm. Sci. 2016;11:476\u2013483.", "ArticleIdList": ["PMC5168884", "28003841"]}, {"Citation": "Memariani T., Hosseini T., Kamali H., Mohammadi A., Ghorbani M., Shakeri A., Spandidos D.A., Tsatsakis A.M., Shahsavand S. Evaluation of the cytotoxic effects of Cyperus longus extract, fractions and its essential oil on the PC3 and MCF7 cancer cell lines. Oncol. Lett. 2016;11:1353\u20131360. doi: 10.3892/ol.2015.4050.", "ArticleIdList": ["10.3892/ol.2015.4050", "PMC4734339", "26893742"]}, {"Citation": "Segat G.C., Manjavachi M.N., Matias D.O., Passos G.F., Freitas C.S., Costa R., Calixto J.B. Antiallodynic effect of beta-caryophyllene on paclitaxel-induced peripheral neuropathy in mice. Neuropharmacology. 2017;125:207\u2013219. doi: 10.1016/j.neuropharm.2017.07.015.", "ArticleIdList": ["10.1016/j.neuropharm.2017.07.015", "28729222"]}, {"Citation": "Bento A.F., Marcon R., Dutra R.C., Claudino R.F., Cola M., Leite D.F., Calixto J.B. beta-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARgamma pathway. Am. J. Pathol. 2011;178:1153\u20131166. doi: 10.1016/j.ajpath.2010.11.052.", "ArticleIdList": ["10.1016/j.ajpath.2010.11.052", "PMC3070571", "21356367"]}, {"Citation": "Gertsch J., Leonti M., Raduner S., Racz I., Chen J.Z., Xie X.Q., Altmann K.H., Karsak M., Zimmer A. Beta-caryophyllene is a dietary cannabinoid. Proc. Natl. Acad. Sci. USA. 2008;105:9099\u20139104. doi: 10.1073/pnas.0803601105.", "ArticleIdList": ["10.1073/pnas.0803601105", "PMC2449371", "18574142"]}, {"Citation": "Alberti T.B., Marcon R., Bicca M.A., Raposo N.R., Calixto J.B., Dutra R.C. Essential oil from Pterodon emarginatus seeds ameliorates experimental autoimmune encephalomyelitis by modulating Th1/Treg cell balance. J. Ethnopharmacol. 2014;155:485\u2013494. doi: 10.1016/j.jep.2014.05.044.", "ArticleIdList": ["10.1016/j.jep.2014.05.044", "24892832"]}, {"Citation": "Alberti T.B., Barbosa W.L., Vieira J.L., Raposo N.R., Dutra R.C. (-)-beta-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis. Int. J. Mol. Sci. 2017;18:691. doi: 10.3390/ijms18040691.", "ArticleIdList": ["10.3390/ijms18040691", "PMC5412277", "28368293"]}, {"Citation": "Fernandes E.S., Passos G.F., Medeiros R., da Cunha F.M., Ferreira J., Campos M.M., Pianowski L.F., Calixto J.B. Anti-inflammatory effects of compounds alpha-humulene and (\u2212)-trans-caryophyllene isolated from the essential oil of Cordia verbenacea. Eur. J. Pharmacol. 2007;569:228\u2013236. doi: 10.1016/j.ejphar.2007.04.059.", "ArticleIdList": ["10.1016/j.ejphar.2007.04.059", "17559833"]}, {"Citation": "Ojha S., Javed H., Azimullah S., Haque M.E. beta-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease. Mol. Cell. Biochem. 2016;418:59\u201370. doi: 10.1007/s11010-016-2733-y.", "ArticleIdList": ["10.1007/s11010-016-2733-y", "27316720"]}, {"Citation": "Sut S., Maggi F., Nicoletti M., Baldan V., Dall Acqua S. New Drugs from Old Natural Compounds: Scarcely Investigated Sesquiterpenes as New Possible Therapeutic Agents. Curr. Med. Chem. 2018;25:1241\u20131258. doi: 10.2174/0929867324666170404150351.", "ArticleIdList": ["10.2174/0929867324666170404150351", "28393689"]}, {"Citation": "Santiago M., Sachdev S., Arnold J.C., McGregor I.S., Connor M. Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Delta(9)-THC at Human CB1 and CB2 Receptors. Cannabis Cannabinoid Res. 2019;4:165\u2013176. doi: 10.1089/can.2019.0016.", "ArticleIdList": ["10.1089/can.2019.0016", "PMC6757242", "31559333"]}, {"Citation": "Sun J. D-Limonene: Safety and clinical applications. Altern. Med. Rev. J. Clin. Ther. 2007;12:259\u2013264.", "ArticleIdList": ["18072821"]}, {"Citation": "Shah B.B., Baksi R., Chaudagar K.K., Nivsarkar M., Mehta A.A. Anti-leukemic and anti-angiogenic effects of d-Limonene on K562-implanted C57BL/6 mice and the chick chorioallantoic membrane model. Anim. Models Exp. Med. 2018;1:328\u2013333. doi: 10.1002/ame2.12039.", "ArticleIdList": ["10.1002/ame2.12039", "PMC6388054", "30891583"]}, {"Citation": "d\u2019Alessio P.A., Ostan R., Bisson J.F., Schulzke J.D., Ursini M.V., Bene M.C. Oral administration of d-limonene controls inflammation in rat colitis and displays anti-inflammatory properties as diet supplementation in humans. Life Sci. 2013;92:1151\u20131156. doi: 10.1016/j.lfs.2013.04.013.", "ArticleIdList": ["10.1016/j.lfs.2013.04.013", "23665426"]}, {"Citation": "Shin M., Liu Q.F., Choi B., Shin C., Lee B., Yuan C., Song Y.J., Yun H.S., Lee I.S., Koo B.S., et al. Neuroprotective effects of limonene (+) against Abeta42-induced neurotoxicity in a Drosophila model of Alzheimer\u2019s disease. Biol. Pharm. Bull. 2019 doi: 10.1248/bpb.b19-00495.", "ArticleIdList": ["10.1248/bpb.b19-00495", "31875578"]}, {"Citation": "de Almeida A.A., Silva R.O., Nicolau L.A., de Brito T.V., de Sousa D.P., Barbosa A.L., de Freitas R.M., Lopes L.D., Medeiros J.R., Ferreira P.M. Physio-pharmacological Investigations About the Anti-inflammatory and Antinociceptive Efficacy of (+)-Limonene Epoxide. Inflammation. 2017;40:511\u2013522. doi: 10.1007/s10753-016-0496-y.", "ArticleIdList": ["10.1007/s10753-016-0496-y", "28091830"]}, {"Citation": "Rozza A.L., Moraes Tde M., Kushima H., Tanimoto A., Marques M.O., Bauab T.M., Hiruma-Lima C.A., Pellizzon C.H. Gastroprotective mechanisms of Citrus lemon (Rutaceae) essential oil and its majority compounds limonene and beta-pinene: Involvement of heat-shock protein-70, vasoactive intestinal peptide, glutathione, sulfhydryl compounds, nitric oxide and prostaglandin E(2) Chem. Biol. Interact. 2011;189:82\u201389.", "ArticleIdList": ["20934418"]}, {"Citation": "de Souza M.C., Vieira A.J., Beserra F.P., Pellizzon C.H., Nobrega R.H., Rozza A.L. Gastroprotective effect of limonene in rats: Influence on oxidative stress, inflammation and gene expression. Phytomed. Int. J. Phytother. Phytopharm. 2019;53:37\u201342. doi: 10.1016/j.phymed.2018.09.027.", "ArticleIdList": ["10.1016/j.phymed.2018.09.027", "30668410"]}, {"Citation": "Wang L., Zhang Y., Fan G., Ren J.N., Zhang L.L., Pan S.Y. Effects of orange essential oil on intestinal microflora in mice. J. Sci. Food Agric. 2019;99:4019\u20134028. doi: 10.1002/jsfa.9629.", "ArticleIdList": ["10.1002/jsfa.9629", "30729524"]}, {"Citation": "do Amaral J.F., Silva M.I., Neto M.R., Neto P.F., Moura B.A., de Melo C.T., de Araujo F.L., de Sousa D.P., de Vasconcelos P.F., de Vasconcelos S.M., et al. Antinociceptive effect of the monoterpene R-(+)-limonene in mice. Biol. Pharm. Bull. 2007;30:1217\u20131220. doi: 10.1248/bpb.30.1217.", "ArticleIdList": ["10.1248/bpb.30.1217", "17603156"]}, {"Citation": "Piccinelli A.C., Santos J.A., Konkiewitz E.C., Oesterreich S.A., Formagio A.S., Croda J., Ziff E.B., Kassuya C.A. Antihyperalgesic and antidepressive actions of (R)-(+)-limonene, alpha-phellandrene, and essential oil from Schinus terebinthifolius fruits in a neuropathic pain model. Nutr. Neurosci. 2015;18:217\u2013224. doi: 10.1179/1476830514Y.0000000119.", "ArticleIdList": ["10.1179/1476830514Y.0000000119", "24661285"]}, {"Citation": "Smeriglio A., Alloisio S., Raimondo F.M., Denaro M., Xiao J., Cornara L., Trombetta D. Essential oil of Citrus lumia Risso: Phytochemical profile, antioxidant properties and activity on the central nervous system. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2018;119:407\u2013416. doi: 10.1016/j.fct.2017.12.053.", "ArticleIdList": ["10.1016/j.fct.2017.12.053", "29288755"]}, {"Citation": "Zhang Y., Wang J., Cao X., Liu W., Yu H., Ye L. High-level production of linalool by engineered Saccharomyces cerevisiae harboring dual mevalonate pathways in mitochondria and cytoplasm. Enzym. Microb. Technol. 2020;134:109462. doi: 10.1016/j.enzmictec.2019.109462.", "ArticleIdList": ["10.1016/j.enzmictec.2019.109462", "32044019"]}, {"Citation": "Kim M.G., Kim S.M., Min J.H., Kwon O.K., Park M.H., Park J.W., Ahn H.I., Hwang J.Y., Oh S.R., Lee J.W., et al. Anti-inflammatory effects of linalool on ovalbumin-induced pulmonary inflammation. Int. Immunopharmacol. 2019;74:105706. doi: 10.1016/j.intimp.2019.105706.", "ArticleIdList": ["10.1016/j.intimp.2019.105706", "31254955"]}, {"Citation": "Sabogal-Guaqueta A.M., Hobbie F., Keerthi A., Oun A., Kortholt A., Boddeke E., Dolga A. Linalool attenuates oxidative stress and mitochondrial dysfunction mediated by glutamate and NMDA toxicity. Biomed. Pharmacother. 2019;118:109295. doi: 10.1016/j.biopha.2019.109295.", "ArticleIdList": ["10.1016/j.biopha.2019.109295", "31545255"]}, {"Citation": "Harada H., Kashiwadani H., Kanmura Y., Kuwaki T. Linalool Odor-Induced Anxiolytic Effects in Mice. Front. Behav. Neurosci. 2018;12:241. doi: 10.3389/fnbeh.2018.00241.", "ArticleIdList": ["10.3389/fnbeh.2018.00241", "PMC6206409", "30405369"]}, {"Citation": "Xu P., Wang K., Lu C., Dong L., Gao L., Yan M., Aibai S., Yang Y., Liu X. Protective effects of linalool against amyloid beta-induced cognitive deficits and damages in mice. Life Sci. 2017;174:21\u201327. doi: 10.1016/j.lfs.2017.02.010.", "ArticleIdList": ["10.1016/j.lfs.2017.02.010", "28235543"]}, {"Citation": "Iwasaki K., Zheng Y.W., Murata S., Ito H., Nakayama K., Kurokawa T., Sano N., Nowatari T., Villareal M.O., Nagano Y.N., et al. Anticancer effect of linalool via cancer-specific hydroxyl radical generation in human colon cancer. World J. Gastroenterol. 2016;22:9765\u20139774. doi: 10.3748/wjg.v22.i44.9765.", "ArticleIdList": ["10.3748/wjg.v22.i44.9765", "PMC5124981", "27956800"]}, {"Citation": "Gunaseelan S., Balupillai A., Govindasamy K., Muthusamy G., Ramasamy K., Shanmugam M., Prasad N.R. The preventive effect of linalool on acute and chronic UVB-mediated skin carcinogenesis in Swiss albino mice. Photochem. Photobiol. Sci. Off. J. Eur. Photochem. Assoc. Eur. Soc. Photobiol. 2016;15:851\u2013860. doi: 10.1039/C6PP00075D.", "ArticleIdList": ["10.1039/C6PP00075D", "27251985"]}, {"Citation": "Katsuyama S., Kuwahata H., Yagi T., Kishikawa Y., Komatsu T., Sakurada T., Nakamura H. Intraplantar injection of linalool reduces paclitaxel-induced acute pain in mice. Biomed. Res. 2012;33:175\u2013181. doi: 10.2220/biomedres.33.175.", "ArticleIdList": ["10.2220/biomedres.33.175", "22790217"]}, {"Citation": "Ibrahim E.A., Wang M., Radwan M.M., Wanas A.S., Majumdar C.G., Avula B., Wang Y.H., Khan I.A., Chandra S., Lata H., et al. Analysis of Terpenes in Cannabis sativa L. Using GC/MS: Method Development, Validation, and Application. Planta Med. 2019;85:431\u2013438. doi: 10.1055/a-0828-8387.", "ArticleIdList": ["10.1055/a-0828-8387", "30646402"]}, {"Citation": "Oliveira M.G., Brito R.G., Santos P.L., Araujo-Filho H.G., Quintans J.S., Menezes P.P., Serafini M.R., Carvalho Y.M., Silva J.C., Almeida J.R., et al. alpha-Terpineol, a monoterpene alcohol, complexed with beta-cyclodextrin exerts antihyperalgesic effect in animal model for fibromyalgia aided with docking study. Chem. Biol. Interact. 2016;254:54\u201362. doi: 10.1016/j.cbi.2016.05.029.", "ArticleIdList": ["10.1016/j.cbi.2016.05.029", "27231091"]}, {"Citation": "Kumar Chaudhari A., Singh A., Kumar Singh V., Kumar Dwivedy A., Das S., Grace Ramsdam M., Dkhar M.S., Kayang H., Kishore Dubey N. Assessment of chitosan biopolymer encapsulated alpha-Terpineol against fungal, aflatoxin B1 (AFB1) and free radicals mediated deterioration of stored maize and possible mode of action. Food Chem. 2020;311:126010. doi: 10.1016/j.foodchem.2019.126010.", "ArticleIdList": ["10.1016/j.foodchem.2019.126010", "31869648"]}, {"Citation": "de Oliveira M.G., Marques R.B., de Santana M.F., Santos A.B., Brito F.A., Barreto E.O., De Sousa D.P., Almeida F.R., Badaue-Passos D., Jr., Antoniolli A.R., et al. alpha-terpineol reduces mechanical hypernociception and inflammatory response. Basic Clin. Pharmacol. Toxicol. 2012;111:120\u2013125.", "ArticleIdList": ["22380944"]}, {"Citation": "Dos Santos Negreiros P., da Costa D.S., da Silva V.G., de Carvalho Lima I.B., Nunes D.B., de Melo Sousa F.B., de Souza Lopes Araujo T., Medeiros J.V.R., Dos Santos R.F., de Cassia Meneses Oliveira R. Antidiarrheal activity of alpha-terpineol in mice. Biomed. Pharmacother. 2019;110:631\u2013640. doi: 10.1016/j.biopha.2018.11.131.", "ArticleIdList": ["10.1016/j.biopha.2018.11.131", "30540974"]}, {"Citation": "Gouveia D.N., Costa J.S., Oliveira M.A., Rabelo T.K., Silva A., Carvalho A.A., Miguel-Dos-Santos R., Lauton-Santos S., Scotti L., Scotti M.T., et al. alpha-Terpineol reduces cancer pain via modulation of oxidative stress and inhibition of iNOS. Biomed. Pharmacother. 2018;105:652\u2013661. doi: 10.1016/j.biopha.2018.06.027.", "ArticleIdList": ["10.1016/j.biopha.2018.06.027", "29902764"]}, {"Citation": "Parvardeh S., Moghimi M., Eslami P., Masoudi A. alpha-Terpineol attenuates morphine-induced physical dependence and tolerance in mice: Role of nitric oxide. Iran. J. Basic Med Sci. 2016;19:201\u2013208.", "ArticleIdList": ["PMC4818369", "27081466"]}, {"Citation": "Moghimi M., Parvardeh S., Zanjani T.M., Ghafghazi S. Protective effect of alpha-terpineol against impairment of hippocampal synaptic plasticity and spatial memory following transient cerebral ischemia in rats. Iran. J. Basic Med Sci. 2016;19:960\u2013969.", "ArticleIdList": ["PMC5080426", "27803783"]}, {"Citation": "Kim K., Bu Y., Jeong S., Lim J., Kwon Y., Cha D.S., Kim J., Jeon S., Eun J., Jeon H. Memory-enhancing effect of a supercritical carbon dioxide fluid extract of the needles of Abies koreana on scopolamine-induced amnesia in mice. Biosci. Biotechnol. Biochem. 2006;70:1821\u20131826. doi: 10.1271/bbb.50608.", "ArticleIdList": ["10.1271/bbb.50608", "16926492"]}, {"Citation": "Nogueira M.N., Aquino S.G., Rossa Junior C., Spolidorio D.M. Terpinen-4-ol and alpha-terpineol (tea tree oil components) inhibit the production of IL-1beta, IL-6 and IL-10 on human macrophages. Inflamm. Res. 2014;63:769\u2013778. doi: 10.1007/s00011-014-0749-x.", "ArticleIdList": ["10.1007/s00011-014-0749-x", "24947163"]}, {"Citation": "Jing G.X., Tao N.G., Jia L., Zhou H.E. Influence of alpha-terpineol on the growth and morphogenesis of Penicillium digitatum. Bot. Stud. 2015;56:35. doi: 10.1186/s40529-015-0116-4.", "ArticleIdList": ["10.1186/s40529-015-0116-4", "PMC5430327", "28510844"]}, {"Citation": "Sharifi-Rad J., Salehi B., Varoni E.M., Sharopov F., Yousaf Z., Ayatollahi S.A., Kobarfard F., Sharifi-Rad M., Afdjei M.H., Sharifi-Rad M., et al. Plants of the Melaleuca Genus as Antimicrobial Agents: From Farm to Pharmacy. Phytother. Res. PTR. 2017;31:1475\u20131494. doi: 10.1002/ptr.5880.", "ArticleIdList": ["10.1002/ptr.5880", "28782167"]}, {"Citation": "Chen Y., Weng Y., Zhou M., Meng Y., Liu J., Yang L., Zuo Z. Linalool- and alpha-terpineol-induced programmed cell death in Chlamydomonas reinhardtii. Ecotoxicol. Environ. Saf. 2019;167:435\u2013440. doi: 10.1016/j.ecoenv.2018.10.062.", "ArticleIdList": ["10.1016/j.ecoenv.2018.10.062", "30368137"]}, {"Citation": "Wua Y., Chenb H.P., Wei J.Y., Yang K., Tian Z.F., Li X.L., Wang P.J., Wang C.F., Du S.S., Cai Q. Repellent Constituents of essential oil from Citrus wilsonii stem barks against Tribolium castaneum. Nat. Prod. Commun. 2014;9:1515\u20131518. doi: 10.1177/1934578X1400901028.", "ArticleIdList": ["10.1177/1934578X1400901028", "25522550"]}, {"Citation": "Villa-Ruano N., Becerra-Martinez E., Cruz-Duran R., Zarate-Reyes J.A., Landeta-Cortes G., Romero-Arenas O. Volatile Profiling, Insecticidal, Antibacterial and Antiproliferative Properties of the Essential Oils of Bursera glabrifolia Leaves. Chem. Biodivers. 2018;15:e1800354. doi: 10.1002/cbdv.201800354.", "ArticleIdList": ["10.1002/cbdv.201800354", "30187618"]}, {"Citation": "Hassan S.B., Gali-Muhtasib H., Goransson H., Larsson R. Alpha terpineol: A potential anticancer agent which acts through suppressing NF-\u03baB signalling. Anticancer Res. 2010;30:1911\u20131919.", "ArticleIdList": ["20651334"]}, {"Citation": "Djenane D., Yanguela J., Amrouche T., Boubrit S., Boussad N., Roncales P. Chemical composition and antimicrobial effects of essential oils of Eucalyptus globulus, Myrtus communis and Satureja hortensis against Escherichia coli O157:H7 and Staphylococcus aureus in minced beef. Food Sci. Technol. Int. = Cienc. Tecnol. Aliment. Int. 2011;17:505\u2013515. doi: 10.1177/1082013211398803.", "ArticleIdList": ["10.1177/1082013211398803", "22049156"]}, {"Citation": "Ramalho T.R., Pacheco de Oliveira M.T., Lima A.L., Bezerra-Santos C.R., Piuvezam M.R. Erratum for: Gamma-Terpinene Modulates Acute Inflammatory Response in Mice. Planta Med. 2015;81:E3. doi: 10.1055/s-0035-1557790.", "ArticleIdList": ["10.1055/s-0035-1557790", "26132854"]}, {"Citation": "Su Y.C., Hsu K.P., Hua K.F., Ho C.L. Composition, in vitro Anti-inflammatory, Antioxidant and Antimicrobial Activities of Essential Oils from Leaf and Twig Parts of Cupressus cashmeriana. Nat. Prod. Commun. 2015;10:1461\u20131464. doi: 10.1177/1934578X1501000837.", "ArticleIdList": ["10.1177/1934578X1501000837", "26434142"]}, {"Citation": "Xavier A.L., Pita J.C., Brito M.T., Meireles D.R., Tavares J.F., Silva M.S., Maia J.G., Andrade E.H., Diniz M.F., Silva T.G., et al. Chemical composition, antitumor activity, and toxicity of essential oil from the leaves of Lippia microphylla. Z. Fur Naturforschung. Cjournal Biosci. 2015;70:129\u2013137. doi: 10.1515/znc-2014-4138.", "ArticleIdList": ["10.1515/znc-2014-4138", "26214608"]}, {"Citation": "Mekonnen A., Tesfaye S., Christos S.G., Dires K., Zenebe T., Zegeye N., Shiferaw Y., Lulekal E. Evaluation of Skin Irritation and Acute and Subacute Oral Toxicity of Lavandula angustifolia Essential Oils in Rabbit and Mice. J. Toxicol. 2019;2019:5979546. doi: 10.1155/2019/5979546.", "ArticleIdList": ["10.1155/2019/5979546", "PMC6369505", "30833968"]}, {"Citation": "Plastina P., Apriantini A., Meijerink J., Witkamp R., Gabriele B., Fazio A. In Vitro Anti-Inflammatory and Radical Scavenging Properties of Chinotto (Citrus myrtifolia Raf.) Essential Oils. Nutrients. 2018;10:783. doi: 10.3390/nu10060783.", "ArticleIdList": ["10.3390/nu10060783", "PMC6024861", "29912150"]}, {"Citation": "Lima Mda S., Quintans-Junior L.J., de Santana W.A., Martins Kaneto C., Pereira Soares M.B., Villarreal C.F. Anti-inflammatory effects of carvacrol: Evidence for a key role of interleukin-10. Eur. J. Pharmacol. 2013;699:112\u2013117. doi: 10.1016/j.ejphar.2012.11.040.", "ArticleIdList": ["10.1016/j.ejphar.2012.11.040", "23220159"]}, {"Citation": "Guimaraes A.G., Quintans J.S., Quintans L.J., Jr. Monoterpenes with analgesic activity--a systematic review. Phytother. Res. PTR. 2013;27:1\u201315. doi: 10.1002/ptr.4686.", "ArticleIdList": ["10.1002/ptr.4686", "23296806"]}, {"Citation": "Siveen K.S., Kuttan G. Thujone inhibits lung metastasis induced by B16F-10 melanoma cells in C57BL/6 mice. Can. J. Physiol. Pharmacol. 2011;89:691\u2013703. doi: 10.1139/y11-067.", "ArticleIdList": ["10.1139/y11-067", "21905822"]}, {"Citation": "Ramalho T.R., Pacheco de Oliveira M.T., Lima A.L., Bezerra-Santos C.R., Piuvezam M.R. Gamma-Terpinene Modulates Acute Inflammatory Response in Mice. Planta Med. 2015;81:1248\u20131254. doi: 10.1055/s-0035-1546169.", "ArticleIdList": ["10.1055/s-0035-1546169", "26132854"]}, {"Citation": "Ramalho T.R., Filgueiras L.R., Pacheco de Oliveira M.T., Lima A.L., Bezerra-Santos C.R., Jancar S., Piuvezam M.R. Gamma-Terpinene Modulation of LPS-Stimulated Macrophages is Dependent on the PGE2/IL-10 Axis. Planta Med. 2016;82:1341\u20131345. doi: 10.1055/s-0042-107799.", "ArticleIdList": ["10.1055/s-0042-107799", "27224271"]}, {"Citation": "Baldissera M.D., Grando T.H., Souza C.F., Gressler L.T., Stefani L.M., da Silva A.S., Monteiro S.G. In vitro and in vivo action of terpinen-4-ol, gamma-terpinene, and alpha-terpinene against Trypanosoma evansi. Exp. Parasitol. 2016;162:43\u201348. doi: 10.1016/j.exppara.2016.01.004.", "ArticleIdList": ["10.1016/j.exppara.2016.01.004", "26773165"]}, {"Citation": "Assmann C.E., Cadona F.C., Bonadiman B., Dornelles E.B., Trevisan G., Cruz I. Tea tree oil presents in vitro antitumor activity on breast cancer cells without cytotoxic effects on fibroblasts and on peripheral blood mononuclear cells. Biomed. Pharmacother. 2018;103:1253\u20131261. doi: 10.1016/j.biopha.2018.04.096.", "ArticleIdList": ["10.1016/j.biopha.2018.04.096", "29864906"]}, {"Citation": "Begum A., Sandhya S., Shaffath Ali S., Vinod K.R., Reddy S., Banji D. An in-depth review on the medicinal flora Rosmarinus officinalis (Lamiaceae) Acta Sci. Polonorum. Technol. Aliment. 2013;12:61\u201373.", "ArticleIdList": ["24584866"]}, {"Citation": "Nissen L., Zatta A., Stefanini I., Grandi S., Sgorbati B., Biavati B., Monti A. Characterization and antimicrobial activity of essential oils of industrial hemp varieties (Cannabis sativa L.) Fitoterapia. 2010;81:413\u2013419. doi: 10.1016/j.fitote.2009.11.010.", "ArticleIdList": ["10.1016/j.fitote.2009.11.010", "19969046"]}, {"Citation": "Yang H., Woo J., Pae A.N., Um M.Y., Cho N.C., Park K.D., Yoon M., Kim J., Lee C.J., Cho S. alpha-Pinene, a Major Constituent of Pine Tree Oils, Enhances Non-Rapid Eye Movement Sleep in Mice through GABAA-benzodiazepine Receptors. Mol. Pharmacol. 2016;90:530\u2013539. doi: 10.1124/mol.116.105080.", "ArticleIdList": ["10.1124/mol.116.105080", "27573669"]}, {"Citation": "Satou T., Kasuya H., Maeda K., Koike K. Daily inhalation of alpha-pinene in mice: Effects on behavior and organ accumulation. Phytother. Res. PTR. 2014;28:1284\u20131287. doi: 10.1002/ptr.5105.", "ArticleIdList": ["10.1002/ptr.5105", "25340185"]}, {"Citation": "Mercier B., Prost J., Prost M. The essential oil of turpentine and its major volatile fraction (alpha- and beta-pinenes): A review. Int. J. Occup. Med. Environ. Health. 2009;22:331\u2013342. doi: 10.2478/v10001-009-0032-5.", "ArticleIdList": ["10.2478/v10001-009-0032-5", "20197260"]}, {"Citation": "Nuutinen T. Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus. Eur. J. Med. Chem. 2018;157:198\u2013228. doi: 10.1016/j.ejmech.2018.07.076.", "ArticleIdList": ["10.1016/j.ejmech.2018.07.076", "30096653"]}, {"Citation": "Kasuya H., Iida S., Ono K., Satou T., Koike K. Intracerebral Distribution of a-Pinene and the Anxiolytic-like Effect in Mice Following Inhaled Administration of Essential Oil from Chamaecyparis obtuse. Nat. Prod. Commun. 2015;10:1479\u20131482. doi: 10.1177/1934578X1501000841.", "ArticleIdList": ["10.1177/1934578X1501000841", "26434146"]}, {"Citation": "Ueno H., Shimada A., Suemitsu S., Murakami S., Kitamura N., Wani K., Matsumoto Y., Okamoto M., Ishihara T. Attenuation Effects of Alpha-Pinene Inhalation on Mice with Dizocilpine-Induced Psychiatric-Like Behaviour. Evid. Based Complement. Altern. Med. ECAM. 2019;2019:2745453. doi: 10.1155/2019/2745453.", "ArticleIdList": ["10.1155/2019/2745453", "PMC6699265", "31467573"]}, {"Citation": "Lee G.Y., Lee C., Park G.H., Jang J.H. Amelioration of Scopolamine-Induced Learning and Memory Impairment by alpha-Pinene in C57BL/6 Mice. Evid. Based Complement. Altern. Med. Ecam. 2017;2017:4926815. doi: 10.1155/2017/4926815.", "ArticleIdList": ["10.1155/2017/4926815", "PMC5687139", "29234406"]}, {"Citation": "Karthikeyan R., Kanimozhi G., Prasad N.R., Agilan B., Ganesan M., Srithar G. Alpha pinene modulates UVA-induced oxidative stress, DNA damage and apoptosis in human skin epidermal keratinocytes. Life Sci. 2018;212:150\u2013158. doi: 10.1016/j.lfs.2018.10.004.", "ArticleIdList": ["10.1016/j.lfs.2018.10.004", "30292828"]}, {"Citation": "Karthikeyan R., Kanimozhi G., Madahavan N.R., Agilan B., Ganesan M., Prasad N.R., Rathinaraj P. Alpha-pinene attenuates UVA-induced photoaging through inhibition of matrix metalloproteinases expression in mouse skin. Life Sci. 2019;217:110\u2013118. doi: 10.1016/j.lfs.2018.12.003.", "ArticleIdList": ["10.1016/j.lfs.2018.12.003", "30521868"]}, {"Citation": "Bouzenna H., Hfaiedh N., Giroux-Metges M.A., Elfeki A., Talarmin H. Potential protective effects of alpha-pinene against cytotoxicity caused by aspirin in the IEC-6 cells. Biomed. Pharmacother. 2017;93:961\u2013968. doi: 10.1016/j.biopha.2017.06.031.", "ArticleIdList": ["10.1016/j.biopha.2017.06.031", "28724214"]}, {"Citation": "Hou J., Zhang Y., Zhu Y., Zhou B., Ren C., Liang S., Guo Y. alpha-Pinene Induces Apoptotic Cell Death via Caspase Activation in Human Ovarian Cancer Cells. Med Sci. Monit.: Int. Med J. Exp. Clin. Res. 2019;25:6631\u20136638. doi: 10.12659/MSM.916419.", "ArticleIdList": ["10.12659/MSM.916419", "PMC6743669", "31482864"]}, {"Citation": "Xu Q., Li M., Yang M., Yang J., Xie J., Lu X., Wang F., Chen W. alpha-pinene regulates miR-221 and induces G2/M phase cell cycle arrest in human hepatocellular carcinoma cells. Biosci. Rep. 2018:38. doi: 10.1042/BSR20180980.", "ArticleIdList": ["10.1042/BSR20180980", "PMC6294613", "30473536"]}, {"Citation": "Rahbar I., Abbasnejad M., Haghani J., Raoof M., Kooshki R., Esmaeili-Mahani S. The effect of central administration of alpha-pinene on capsaicin-induced dental pulp nociception. Int. Endod. J. 2019;52:307\u2013317. doi: 10.1111/iej.13006.", "ArticleIdList": ["10.1111/iej.13006", "30152861"]}, {"Citation": "Li X.J., Yang Y.J., Li Y.S., Zhang W.K., Tang H.B. alpha-Pinene, linalool, and 1-octanol contribute to the topical anti-inflammatory and analgesic activities of frankincense by inhibiting COX-2. J. Ethnopharmacol. 2016;179:22\u201326. doi: 10.1016/j.jep.2015.12.039.", "ArticleIdList": ["10.1016/j.jep.2015.12.039", "26721216"]}, {"Citation": "Iseppi R., Brighenti V., Licata M., Lambertini A., Sabia C., Messi P., Pellati F., Benvenuti S. Chemical Characterization and Evaluation of the Antibacterial Activity of Essential Oils from Fibre-Type Cannabis sativa L. (Hemp) Molecules. 2019;24:2302. doi: 10.3390/molecules24122302.", "ArticleIdList": ["10.3390/molecules24122302", "PMC6631254", "31234360"]}, {"Citation": "Pertwee R.G.E. Handbook of Cannabis. 1st ed. Oxford University Press; London, UK: 2016."}, {"Citation": "Mahajan P., Singh H.P., Kaur S., Batish D.R., Kohli R.K. beta-Pinene moderates Cr(VI) phytotoxicity by quenching reactive oxygen species and altering antioxidant machinery in maize. Environ. Sci. Pollut. Res. Int. 2019;26:456\u2013463. doi: 10.1007/s11356-018-3562-1.", "ArticleIdList": ["10.1007/s11356-018-3562-1", "30406586"]}, {"Citation": "Pajaro-Castro N., Caballero-Gallardo K., Olivero-Verbel J. Neurotoxic Effects of Linalool and beta-Pinene on Tribolium castaneum Herbst. Molecules. 2017;22:2052. doi: 10.3390/molecules22122052.", "ArticleIdList": ["10.3390/molecules22122052", "PMC6149882", "29186788"]}, {"Citation": "Guzman-Gutierrez S.L., Gomez-Cansino R., Garcia-Zebadua J.C., Jimenez-Perez N.C., Reyes-Chilpa R. Antidepressant activity of Litsea glaucescens essential oil: Identification of beta-pinene and linalool as active principles. J. Ethnopharmacol. 2012;143:673\u2013679. doi: 10.1016/j.jep.2012.07.026.", "ArticleIdList": ["10.1016/j.jep.2012.07.026", "22867633"]}, {"Citation": "Guzman-Gutierrez S.L., Bonilla-Jaime H., Gomez-Cansino R., Reyes-Chilpa R. Linalool and beta-pinene exert their antidepressant-like activity through the monoaminergic pathway. Life Sci. 2015;128:24\u201329. doi: 10.1016/j.lfs.2015.02.021.", "ArticleIdList": ["10.1016/j.lfs.2015.02.021", "25771248"]}, {"Citation": "Wang Y., Wu C., Zhang Q., Shan Y., Gu W., Wang S. Design, synthesis and biological evaluation of novel beta-pinene-based thiazole derivatives as potential anticancer agents via mitochondrial-mediated apoptosis pathway. Bioorg. Chem. 2019;84:468\u2013477. doi: 10.1016/j.bioorg.2018.12.010.", "ArticleIdList": ["10.1016/j.bioorg.2018.12.010", "30576910"]}, {"Citation": "Astani A., Reichling J., Schnitzler P. Comparative study on the antiviral activity of selected monoterpenes derived from essential oils. Phytother. Res. PTR. 2010;24:673\u2013679. doi: 10.1002/ptr.2955.", "ArticleIdList": ["10.1002/ptr.2955", "PMC7167768", "19653195"]}, {"Citation": "Zhou L., Zhang Z., Wei M., Xie Y., He S., Shi H., Lin Z. Evaluation of the antifungal activity of individual and combined monoterpenes against Rhizopus stolonifer and Absidia coerulea. Environ. Sci. Pollut. Res. Int. 2019;26:7804\u20137809. doi: 10.1007/s11356-019-04278-z.", "ArticleIdList": ["10.1007/s11356-019-04278-z", "30675711"]}, {"Citation": "Astani A., Schnitzler P. Antiviral activity of monoterpenes beta-pinene and limonene against herpes simplex virus in vitro. Iran. J. Microbiol. 2014;6:149\u2013155.", "ArticleIdList": ["PMC4393490", "25870747"]}, {"Citation": "de Macedo Andrade A.C., Rosalen P.L., Freires I.A., Scotti L., Scotti M.T., Aquino S.G., de Castro R.D. Antifungal Activity, Mode of Action, Docking Prediction and Anti-biofilm Effects of (+)-beta-pinene Enantiomers against Candida spp. Curr. Top. Med. Chem. 2018;18:2481\u20132490. doi: 10.2174/1568026618666181115103104.", "ArticleIdList": ["10.2174/1568026618666181115103104", "30430938"]}, {"Citation": "Jia N., Arthington-Skaggs B., Lee W., Pierson C.A., Lees N.D., Eckstein J., Barbuch R., Bard M. Candida albicans sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target site. Antimicrob. Agents Chemother. 2002;46:947\u2013957. doi: 10.1128/AAC.46.4.947-957.2002.", "ArticleIdList": ["10.1128/AAC.46.4.947-957.2002", "PMC127109", "11897574"]}, {"Citation": "Rivas da Silva A.C., Lopes P.M., Barros de Azevedo M.M., Costa D.C., Alviano C.S., Alviano D.S. Biological activities of alpha-pinene and beta-pinene enantiomers. Molecules. 2012;17:6305\u20136316. doi: 10.3390/molecules17066305.", "ArticleIdList": ["10.3390/molecules17066305", "PMC6268778", "22634841"]}, {"Citation": "Marchini M., Charvoz C., Dujourdy L., Baldovini N., Filippi J.J. Multidimensional analysis of cannabis volatile constituents: Identification of 5,5-dimethyl-1-vinylbicyclo[2.1.1]hexane as a volatile marker of hashish, the resin of Cannabis sativa L. J. Chromatography. A. 2014;1370:200\u2013215. doi: 10.1016/j.chroma.2014.10.045.", "ArticleIdList": ["10.1016/j.chroma.2014.10.045", "25454145"]}, {"Citation": "Booth J.K., Bohlmann J. Terpenes in Cannabis sativa\u2014From plant genome to humans. Plant Sci. Int. J. Exp. Plant Biol. 2019;284:67\u201372. doi: 10.1016/j.plantsci.2019.03.022.", "ArticleIdList": ["10.1016/j.plantsci.2019.03.022", "31084880"]}, {"Citation": "Zhai B., Zhang N., Han X., Li Q., Zhang M., Chen X., Li G., Zhang R., Chen P., Wang W., et al. Molecular targets of beta-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: A review. Biomed. Pharmacother. 2019;114:108812. doi: 10.1016/j.biopha.2019.108812.", "ArticleIdList": ["10.1016/j.biopha.2019.108812", "30965237"]}, {"Citation": "Deng M., Zhang Y., Liu B., Chen Y., Song H., Yu R., Che X., Qu X., Liu Y., Hu X., et al. beta-Elemene inhibits peritoneal metastasis of gastric cancer cells by modulating FAK/Claudin-1 signaling. Phytother. Res. PTR. 2019;33:2448\u20132456. doi: 10.1002/ptr.6436.", "ArticleIdList": ["10.1002/ptr.6436", "31342604"]}, {"Citation": "Wu Z., Wang T., Zhang Y., Zheng Z., Yu S., Jing S., Chen S., Jiang H., Ma S. Anticancer effects of beta-elemene with hyperthermia in lung cancer cells. Exp. Ther. Med. 2017;13:3153\u20133157. doi: 10.3892/etm.2017.4350.", "ArticleIdList": ["10.3892/etm.2017.4350", "PMC5450781", "28588670"]}, {"Citation": "Fang M., Mei X., Yao H., Zhang T., Zhang T., Lu N., Liu Y., Xu W., Wan C. beta-elemene enhances anticancer and anti-metastatic effects of osteosarcoma of ligustrazine in vitro and in vivo. Oncol. Lett. 2018;15:3957\u20133964.", "ArticleIdList": ["PMC5795946", "29467906"]}, {"Citation": "Cai B., Ma L., Nong S., Wu Y., Guo X., Pu J. beta-elemene induced anticancer effect in bladder cancer through upregulation of PTEN and suppression of AKT phosphorylation. Oncol. Lett. 2018;16:6019\u20136025.", "ArticleIdList": ["PMC6176406", "30333873"]}, {"Citation": "Liu J.S., He S.C., Zhang Z.L., Chen R., Fan L., Qiu G.L., Chang S., Li L., Che X.M. Anticancer effects of beta-elemene in gastric cancer cells and its potential underlying proteins: A proteomic study. Oncol. Rep. 2014;32:2635\u20132647. doi: 10.3892/or.2014.3490.", "ArticleIdList": ["10.3892/or.2014.3490", "25333415"]}, {"Citation": "Li Q.Q., Lee R.X., Liang H., Zhong Y. Anticancer activity of beta-Elemene and its synthetic analogs in human malignant brain tumor cells. Anticancer Res. 2013;33:65\u201376.", "ArticleIdList": ["PMC3737582", "23267129"]}, {"Citation": "Wei Y., Pu X., Zhao L. Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy. Oncol. Rep. 2017;37:3159\u20133166. doi: 10.3892/or.2017.5593.", "ArticleIdList": ["10.3892/or.2017.5593", "28440434"]}, {"Citation": "Li X., Gao C., Wu Y., Cheng C.Y., Xia W., Zhang Z. Combination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cells. J. Mater. Chem. B. 2015;3:1556\u20131564. doi: 10.1039/C4TB01764A.", "ArticleIdList": ["10.1039/C4TB01764A", "PMC4865403", "27182439"]}, {"Citation": "Yao Y.Q., Ding X., Jia Y.C., Huang C.X., Wang Y.Z., Xu Y.H. Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer Lett. 2008;264:127\u2013134. doi: 10.1016/j.canlet.2008.01.049.", "ArticleIdList": ["10.1016/j.canlet.2008.01.049", "18442668"]}, {"Citation": "Jiang Z., Jacob J.A., Loganathachetti D.S., Nainangu P., Chen B. beta-Elemene: Mechanistic Studies on Cancer Cell Interaction and Its Chemosensitization Effect. Front. Pharmacol. 2017;8:105. doi: 10.3389/fphar.2017.00105.", "ArticleIdList": ["10.3389/fphar.2017.00105", "PMC5343065", "28337141"]}, {"Citation": "Li Q.Q., Wang G., Zhang M., Cuff C.F., Huang L., Reed E. beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis. Oncol. Rep. 2009;22:161\u2013170. doi: 10.3892/or_00000420.", "ArticleIdList": ["10.3892/or_00000420", "19513519"]}, {"Citation": "Eloy J.O., Claro de Souza M., Petrilli R., Barcellos J.P., Lee R.J., Marchetti J.M. Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery. Colloids Surf. Biointerfaces. 2014;123:345\u2013363. doi: 10.1016/j.colsurfb.2014.09.029.", "ArticleIdList": ["10.1016/j.colsurfb.2014.09.029", "25280609"]}, {"Citation": "Cao M., Long M., Chen Q., Lu Y., Luo Q., Zhao Y., Lu A., Ge C., Zhu L., Chen Z. Development of beta-elemene and Cisplatin Co-Loaded Liposomes for Effective Lung Cancer Therapy and Evaluation in Patient-Derived Tumor Xenografts. Pharm. Res. 2019;36:121. doi: 10.1007/s11095-019-2656-x.", "ArticleIdList": ["10.1007/s11095-019-2656-x", "31214786"]}, {"Citation": "Cao C., Wang Q., Liu Y. Lung cancer combination therapy: Doxorubicin and beta-elemene co-loaded, pH-sensitive nanostructured lipid carriers. Drug Des. Dev. Ther. 2019;13:1087\u20131098. doi: 10.2147/DDDT.S198003.", "ArticleIdList": ["10.2147/DDDT.S198003", "PMC6498957", "31118562"]}, {"Citation": "Zeng Y.Y., Zeng Y.J., Zhang N.N., Li C.X., Xie T., Zeng Z.W. The Preparation, Determination of a Flexible Complex Liposome Co-Loaded with Cabazitaxel and beta-Elemene, and Animal Pharmacodynamics on Paclitaxel-Resistant Lung Adenocarcinoma. Molecules. 2019;24:1697. doi: 10.3390/molecules24091697.", "ArticleIdList": ["10.3390/molecules24091697", "PMC6539285", "31052317"]}, {"Citation": "Yoshida T., Hashimura M., Mastumoto T., Tazo Y., Inoue H., Kuwata T., Saegusa M. Transcriptional upregulation of HIF-1alpha by NF-\u03baB/p65 and its associations with beta-catenin/p300 complexes in endometrial carcinoma cells. Lab. Investig. J. Tech. Methods Pathol. 2013;93:1184\u20131193. doi: 10.1038/labinvest.2013.111.", "ArticleIdList": ["10.1038/labinvest.2013.111", "24042437"]}, {"Citation": "Yu X., Li Z., Zhang Y., Xu M., Che Y., Tian X., Wang R., Zou K., Zou L. beta-elemene inhibits radiation and hypoxia-induced macrophages infiltration via Prx-1/NF-\u03baB/HIF-1alpha signaling pathway. Oncotargets Ther. 2019;12:4203\u20134211. doi: 10.2147/OTT.S196910.", "ArticleIdList": ["10.2147/OTT.S196910", "PMC6549424", "31213838"]}, {"Citation": "Liu M., Chen X., Ma J., Hassan W., Wu H., Ling J., Shang J. beta-Elemene attenuates atherosclerosis in apolipoprotein E-deficient mice via restoring NO levels and alleviating oxidative stress. Biomed. Pharmacother. 2017;95:1789\u20131798. doi: 10.1016/j.biopha.2017.08.092.", "ArticleIdList": ["10.1016/j.biopha.2017.08.092", "28962084"]}, {"Citation": "Zhou Y., Liu Y., Chen J., Sun Y.Z., Li L.H., Chen L. Inhibition of beta-elemene on the expressions of HIF-lalpha, VEGF and iNOS in diabetic rats model. Int. J. Ophthalmol. 2019;12:1693\u20131698. doi: 10.18240/ijo.2019.11.05.", "ArticleIdList": ["10.18240/ijo.2019.11.05", "PMC6848882", "31741856"]}, {"Citation": "Zhang R., Tian A., Shi X., Yu H., Chen L. Downregulation of IL-17 and IFN-gamma in the optic nerve by beta-elemene in experimental autoimmune encephalomyelitis. Int. Immunopharmacol. 2010;10:738\u2013743. doi: 10.1016/j.intimp.2010.04.003.", "ArticleIdList": ["10.1016/j.intimp.2010.04.003", "20399285"]}, {"Citation": "Farre-Armengol G., Filella I., Llusia J., Penuelas J. beta-Ocimene, a Key Floral and Foliar Volatile Involved in Multiple Interactions between Plants and Other Organisms. Molecules. 2017;22:1148. doi: 10.3390/molecules22071148.", "ArticleIdList": ["10.3390/molecules22071148", "PMC6152128", "28703755"]}, {"Citation": "Pavlovic R., Panseri S., Giupponi L., Leoni V., Citti C., Cattaneo C., Cavaletto M., Giorgi A. Phytochemical and Ecological Analysis of Two Varieties of Hemp (Cannabis sativa L.) Grown in a Mountain Environment of Italian Alps. Front. Plant Sci. 2019;10:1265. doi: 10.3389/fpls.2019.01265.", "ArticleIdList": ["10.3389/fpls.2019.01265", "PMC6822994", "31708938"]}, {"Citation": "Bomfim L.M., Menezes L.R., Rodrigues A.C., Dias R.B., Rocha C.A., Soares M.B., Neto A.F., Nascimento M.P., Campos A.F., Silva L.C., et al. Antitumour Activity of the Microencapsulation of Annona vepretorum Essential Oil. Basic Clin. Pharmacol. Toxicol. 2016;118:208\u2013213. doi: 10.1111/bcpt.12488.", "ArticleIdList": ["10.1111/bcpt.12488", "26348780"]}, {"Citation": "Sayyah M., Nadjafnia L., Kamalinejad M. Anticonvulsant activity and chemical composition of Artemisia dracunculus L. essential oil. J. Ethnopharmacol. 2004;94:283\u2013287. doi: 10.1016/j.jep.2004.05.021.", "ArticleIdList": ["10.1016/j.jep.2004.05.021", "15325732"]}, {"Citation": "Bas\\er K.H.C., Buchbauer G. Handbook of Essential Oils: Science, Technology, and Applications. CRC Press/Taylor & Francis; Boca Raton, FL, USA: 2010."}, {"Citation": "Feng Y.X., Wang Y., Chen Z.Y., Guo S.S., You C.X., Du S.S. Efficacy of bornyl acetate and camphene from Valeriana officinalis essential oil against two storage insects. Environ. Sci. Pollut. Res. Int. 2019;26:16157\u201316165. doi: 10.1007/s11356-019-05035-y.", "ArticleIdList": ["10.1007/s11356-019-05035-y", "30972667"]}, {"Citation": "Benelli G., Govindarajan M., Rajeswary M., Vaseeharan B., Alyahya S.A., Alharbi N.S., Kadaikunnan S., Khaled J.M., Maggi F. Insecticidal activity of camphene, zerumbone and alpha-humulene from Cheilocostus speciosus rhizome essential oil against the Old-World bollworm, Helicoverpa armigera. Ecotoxicol. Environ. Saf. 2018;148:781\u2013786. doi: 10.1016/j.ecoenv.2017.11.044.", "ArticleIdList": ["10.1016/j.ecoenv.2017.11.044", "29190597"]}, {"Citation": "Benelli G., Govindarajan M., AlSalhi M.S., Devanesan S., Maggi F. High toxicity of camphene and gamma-elemene from Wedelia prostrata essential oil against larvae of Spodoptera litura (Lepidoptera: Noctuidae) Environ. Sci. Pollut. Res. Int. 2018;25:10383\u201310391. doi: 10.1007/s11356-017-9490-7.", "ArticleIdList": ["10.1007/s11356-017-9490-7", "28634795"]}, {"Citation": "Souza M.R.P., Coelho N.P., Baldin V.P., Scodro R.B.L., Cardoso R.F., da Silva C.C., Vandresen F. Synthesis of novel (\u2212)-Camphene-based thiosemicarbazones and evaluation of anti-Mycobacterium tuberculosis activity. Nat. Prod. Res. 2019;33:3372\u20133377. doi: 10.1080/14786419.2018.1478829.", "ArticleIdList": ["10.1080/14786419.2018.1478829", "29792346"]}, {"Citation": "Baldissera M.D., Souza C.F., Rieffel R.C., Velho M.C., Ramos A.P., Nascimento K., Sagrillo M.R., Ourique A.F., da Silva A.S., Stefani L.M., et al. Protective effect of nerolidol-loaded in nanospheres against cerebral damage caused by Trypanosoma evansi. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 2018;391:753\u2013759. doi: 10.1007/s00210-018-1504-6.", "ArticleIdList": ["10.1007/s00210-018-1504-6", "29691607"]}, {"Citation": "Ceole L.F., Cardoso M.D.G., Soares M.J. Nerolidol, the main constituent of Piper aduncum essential oil, has anti-Leishmania braziliensis activity. Parasitology. 2017;144:1179\u20131190. doi: 10.1017/S0031182017000452.", "ArticleIdList": ["10.1017/S0031182017000452", "28482935"]}, {"Citation": "Alonso L., Fernandes K.S., Mendanha S.A., Goncalves P.J., Gomes R.S., Dorta M.L., Alonso A. In vitro antileishmanial and cytotoxic activities of nerolidol are associated with changes in plasma membrane dynamics. Biochim. Biophys. Acta Biomembr. 2019;1861:1049\u20131056. doi: 10.1016/j.bbamem.2019.03.006.", "ArticleIdList": ["10.1016/j.bbamem.2019.03.006", "30890467"]}, {"Citation": "Silva M.P., de Oliveira R.N., Mengarda A.C., Roquini D.B., Allegretti S.M., Salvadori M.C., Teixeira F.S., de Sousa D.P., Pinto P.L.S., da Silva Filho A.A., et al. Antiparasitic activity of nerolidol in a mouse model of schistosomiasis. Int. J. Antimicrob. Agents. 2017;50:467\u2013472. doi: 10.1016/j.ijantimicag.2017.06.005.", "ArticleIdList": ["10.1016/j.ijantimicag.2017.06.005", "28666754"]}, {"Citation": "Zhang L., Sun D., Bao Y., Shi Y., Cui Y., Guo M. Nerolidol Protects Against LPS-induced Acute Kidney Injury via Inhibiting TLR4/NF-\u03baB Signaling. Phytother. Res. PTR. 2017;31:459\u2013465. doi: 10.1002/ptr.5770.", "ArticleIdList": ["10.1002/ptr.5770", "28093813"]}, {"Citation": "Barros Silva Soares de Souza E.P., Trindade G., Lins Dantas Gomes M.V., Santos Silva L.A., Grespan R., Quintans Junior L.J., Cavalcanti de Albuquerque Junior R.L., Shanmugan S., Antunes de Souza Araujo A. Anti-inflammatory effect of nano-encapsulated nerolidol on zymosan-induced arthritis in mice. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2019:110958. doi: 10.1016/j.fct.2019.110958.", "ArticleIdList": ["10.1016/j.fct.2019.110958", "31715307"]}, {"Citation": "Hanusova V., Caltova K., Svobodova H., Ambroz M., Skarka A., Murinova N., Kralova V., Tomsik P., Skalova L. The effects of beta-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice. Biomed. Pharmacother. 2017;95:828\u2013836. doi: 10.1016/j.biopha.2017.09.008.", "ArticleIdList": ["10.1016/j.biopha.2017.09.008", "28903178"]}, {"Citation": "Iqubal A., Sharma S., Najmi A.K., Syed M.A., Ali J., Alam M.M., Haque S.E. Nerolidol ameliorates cyclophosphamide-induced oxidative stress, neuroinflammation and cognitive dysfunction: Plausible role of Nrf2 and NF-\u03baB. Life Sci. 2019;236:116867. doi: 10.1016/j.lfs.2019.116867.", "ArticleIdList": ["10.1016/j.lfs.2019.116867", "31520598"]}, {"Citation": "Iqubal A., Sharma S., Ansari M.A., Najmi A.K., Syed M.A., Ali J., Alam M.M., Ahmad S., Haque S.E. Nerolidol attenuates cyclophosphamide-induced cardiac inflammation, apoptosis and fibrosis in Swiss Albino mice. Eur. J. Pharmacol. 2019;863:172666. doi: 10.1016/j.ejphar.2019.172666.", "ArticleIdList": ["10.1016/j.ejphar.2019.172666", "31541628"]}, {"Citation": "Asaikumar L., Vennila L., Akila P., Sivasangari S., Kanimozhi K., Premalatha V., Sindhu G. Preventive effect of nerolidol on isoproterenol induced myocardial damage in Wistar rats: Evidences from biochemical and histopathological studies. Drug Dev. Res. 2019;80:814\u2013823. doi: 10.1002/ddr.21564.", "ArticleIdList": ["10.1002/ddr.21564", "31313346"]}, {"Citation": "Pellati F., Borgonetti V., Brighenti V., Biagi M., Benvenuti S., Corsi L. Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer. Biomed Res. Int. 2018;2018:1691428. doi: 10.1155/2018/1691428.", "ArticleIdList": ["10.1155/2018/1691428", "PMC6304621", "30627539"]}, {"Citation": "Betancur-Galvis L.A., Morales G.E., Forero J.E., Roldan J. Cytotoxic and antiviral activities of Colombian medicinal plant extracts of the Euphorbia genus. Mem. Inst. Oswaldo Cruz. 2002;97:541\u2013546. doi: 10.1590/S0074-02762002000400017.", "ArticleIdList": ["10.1590/S0074-02762002000400017", "12118288"]}, {"Citation": "Nes W.D., Wong R.Y., Benson M., Landrey J.R., Nes W.R. Rotational isomerism about the 17(20)-bond of steroids and euphoids as shown by the crystal structures of euphol and tirucallol. Proc. Natl. Acad. Sci. USA. 1984;81:5896\u20135900. doi: 10.1073/pnas.81.18.5896.", "ArticleIdList": ["10.1073/pnas.81.18.5896", "PMC391822", "6592593"]}, {"Citation": "Xie X., Li Y., Gao D., Zhang Y., Ren Y. Quantitative determination of euphol in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. Biomed. Chromatogr. BMC. 2014;28:1229\u20131234. doi: 10.1002/bmc.3151.", "ArticleIdList": ["10.1002/bmc.3151", "25237707"]}, {"Citation": "de Souza L.S., Puziol L.C., Tosta C.L., Bittencourt M.L.F., Ardisson J.S., Kitagawa R.R., Filgueiras P.R., Kuster R.M. Analytical methods to access the chemical composition of an Euphorbia tirucalli anticancer latex from traditional Brazilian medicine. J. Ethnopharmacol. 2019;237:255\u2013265. doi: 10.1016/j.jep.2019.03.041.", "ArticleIdList": ["10.1016/j.jep.2019.03.041", "30928500"]}, {"Citation": "Prinsloo G., Marokane C.K., Street R.A. Anti-HIV activity of southern African plants: Current developments, phytochemistry and future research. J. Ethnopharmacol. 2018;210:133\u2013155. doi: 10.1016/j.jep.2017.08.005.", "ArticleIdList": ["10.1016/j.jep.2017.08.005", "PMC7125770", "28807850"]}, {"Citation": "Mazoir N., Benharref A., Bailen M., Reina M., Gonzalez-Coloma A., Martinez-Diaz R.A. Antileishmanial and antitrypanosomal activity of triterpene derivatives from latex of two Euphorbia species. Z. Fur Naturforschung. Cjournal Biosci. 2011;66:360\u2013366. doi: 10.1515/znc-2011-7-807.", "ArticleIdList": ["10.1515/znc-2011-7-807", "21950160"]}, {"Citation": "Ibrahim E.H., Kilany M., Mostafa O.M.S., Shaker K.H., Alshehri M., Alsyaad K.M., Alshehri A., Khan K.A., Qasim M., Kotb N., et al. TH1/TH2 chemokines/cytokines profile in rats treated with tetanus toxoid and Euphorbia tirucalli. Saudi J. Biol. Sci. 2019;26:1716\u20131723. doi: 10.1016/j.sjbs.2018.08.005.", "ArticleIdList": ["10.1016/j.sjbs.2018.08.005", "PMC6864399", "31762649"]}, {"Citation": "Silva V.A.O., Rosa M.N., Tansini A., Oliveira R.J.S., Martinho O., Lima J.P., Pianowski L.F., Reis R.M. In vitro screening of cytotoxic activity of euphol from Euphorbia tirucalli on a large panel of human cancer-derived cell lines. Exp. Ther. Med. 2018;16:557\u2013566. doi: 10.3892/etm.2018.6244.", "ArticleIdList": ["10.3892/etm.2018.6244", "PMC6090420", "30112023"]}, {"Citation": "Cruz L.S., de Oliveira T.L., Kanunfre C.C., Paludo K.S., Minozzo B.R., Prestes A.P., Wang M., Fernandes D., Santos F.A.D., Manda V.K., et al. Pharmacokinetics and cytotoxic study of euphol from Euphorbia umbellata (Bruyns) Pax latex. Phytomedicine: Int. J. Phytother. Phytopharm. 2018;47:105\u2013112. doi: 10.1016/j.phymed.2018.04.055.", "ArticleIdList": ["10.1016/j.phymed.2018.04.055", "30166094"]}, {"Citation": "Wang L., Wang G., Yang D., Guo X., Xu Y., Feng B., Kang J. Euphol arrests breast cancer cells at the G1 phase through the modulation of cyclin D1, p21 and p27 expression. Mol. Med. Rep. 2013;8:1279\u20131285. doi: 10.3892/mmr.2013.1650.", "ArticleIdList": ["10.3892/mmr.2013.1650", "23969579"]}, {"Citation": "Silva V.A.O., Rosa M.N., Miranda-Goncalves V., Costa A.M., Tansini A., Evangelista A.F., Martinho O., Carloni A.C., Jones C., Lima J.P., et al. Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells. Investig. New Drugs. 2019;37:223\u2013237. doi: 10.1007/s10637-018-0620-y.", "ArticleIdList": ["10.1007/s10637-018-0620-y", "29931585"]}, {"Citation": "Athmouni K., El Feki A., Ayadi H. Hepatotoxic effects of Euphol-rich fractions from Euphorbia bivonae-Relevance to cytotoxic and anti-tumor activities. Pathophysiol. Off. J. Int. Soc. Pathophysiol. 2019;26:69\u201376. doi: 10.1016/j.pathophys.2018.10.003.", "ArticleIdList": ["10.1016/j.pathophys.2018.10.003", "30401578"]}, {"Citation": "Dutra R.C., Claudino R.F., Bento A.F., Marcon R., Schmidt E.C., Bouzon Z.L., Pianowski L.F., Calixto J.B. Preventive and therapeutic euphol treatment attenuates experimental colitis in mice. PLoS ONE. 2011;6:e27122. doi: 10.1371/journal.pone.0027122.", "ArticleIdList": ["10.1371/journal.pone.0027122", "PMC3206917", "22073270"]}, {"Citation": "Dutra R.C., de Souza P.R., Bento A.F., Marcon R., Bicca M.A., Pianowski L.F., Calixto J.B. Euphol prevents experimental autoimmune encephalomyelitis in mice: Evidence for the underlying mechanisms. Biochem. Pharmacol. 2012;83:531\u2013542. doi: 10.1016/j.bcp.2011.11.026.", "ArticleIdList": ["10.1016/j.bcp.2011.11.026", "22155310"]}, {"Citation": "Yasukawa K., Akihisa T., Yoshida Z.Y., Takido M. Inhibitory effect of euphol, a triterpene alcohol from the roots of Euphorbia kansui, on tumour promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. J. Pharm. Pharmacol. 2000;52:119\u2013124. doi: 10.1211/0022357001773607.", "ArticleIdList": ["10.1211/0022357001773607", "10716613"]}, {"Citation": "Passos G.F., Medeiros R., Marcon R., Nascimento A.F., Calixto J.B., Pianowski L.F. The role of PKC/ERK1/2 signaling in the anti-inflammatory effect of tetracyclic triterpene euphol on TPA-induced skin inflammation in mice. Eur. J. Pharmacol. 2013;698:413\u2013420. doi: 10.1016/j.ejphar.2012.10.019.", "ArticleIdList": ["10.1016/j.ejphar.2012.10.019", "23099255"]}, {"Citation": "Dutra R.C., Simao da Silva K.A., Bento A.F., Marcon R., Paszcuk A.F., Meotti F.C., Pianowski L.F., Calixto J.B. Euphol, a tetracyclic triterpene produces antinociceptive effects in inflammatory and neuropathic pain: The involvement of cannabinoid system. Neuropharmacology. 2012;63:593\u2013605. doi: 10.1016/j.neuropharm.2012.05.008.", "ArticleIdList": ["10.1016/j.neuropharm.2012.05.008", "22613837"]}, {"Citation": "Dutra R.C., Bicca M.A., Segat G.C., Silva K.A., Motta E.M., Pianowski L.F., Costa R., Calixto J.B. The antinociceptive effects of the tetracyclic triterpene euphol in inflammatory and neuropathic pain models: The potential role of PKCepsilon. Neuroscience. 2015;303:126\u2013137. doi: 10.1016/j.neuroscience.2015.06.051.", "ArticleIdList": ["10.1016/j.neuroscience.2015.06.051", "26143011"]}, {"Citation": "Yang C., Kennes Y.M., Lepp D., Yin X., Wang Q., Yu H., Yang C., Gong J., Diarra M.S. Effects of encapsulated cinnamaldehyde and citral on the performance and cecal microbiota of broilers vaccinated or not vaccinated against coccidiosis. Poult. Sci. 2020;99:936\u2013948. doi: 10.1016/j.psj.2019.10.036.", "ArticleIdList": ["10.1016/j.psj.2019.10.036", "PMC7587813", "32029170"]}, {"Citation": "Shi C., Song K., Zhang X., Sun Y., Sui Y., Chen Y., Jia Z., Sun H., Sun Z., Xia X. Antimicrobial Activity and Possible Mechanism of Action of Citral against Cronobacter sakazakii. PLoS ONE. 2016;11:e0159006. doi: 10.1371/journal.pone.0159006.", "ArticleIdList": ["10.1371/journal.pone.0159006", "PMC4945043", "27415761"]}, {"Citation": "Parra-Flores J., Cerda-Leal F., Contreras A., Valenzuela-Riffo N., Rodriguez A., Aguirre J. Cronobacter sakazakii and Microbiological Parameters in Dairy Formulas Associated With a Food Alert in Chile. Front. Microbiol. 2018;9:1708. doi: 10.3389/fmicb.2018.01708.", "ArticleIdList": ["10.3389/fmicb.2018.01708", "PMC6079297", "30108565"]}, {"Citation": "Gupta P., Patel D.K., Gupta V.K., Pal A., Tandon S., Darokar M.P. Citral, a monoterpenoid aldehyde interacts synergistically with norfloxacin against methicillin resistant Staphylococcus aureus. Phytomed. Int. J. Phytother. Phytopharm. 2017;34:85\u201396. doi: 10.1016/j.phymed.2017.08.016.", "ArticleIdList": ["10.1016/j.phymed.2017.08.016", "28899514"]}, {"Citation": "Leite M.C., Bezerra A.P., de Sousa J.P., Guerra F.Q., Lima Ede O. Evaluation of Antifungal Activity and Mechanism of Action of Citral against Candida albicans. Evid. Based Complement. Altern. Med. ECAM. 2014;2014:378280. doi: 10.1155/2014/378280.", "ArticleIdList": ["10.1155/2014/378280", "PMC4163309", "25250053"]}, {"Citation": "Qian W., Liu M., Fu Y., Wang T., Zhang J., Yang M., Sun Z., Li X., Li Y. Antimicrobial and Antibiofilm Activities of Citral against Carbapenem-Resistant Enterobacter cloacae. Foodborne Pathog. Dis. 2020 doi: 10.1089/fpd.2019.2751.", "ArticleIdList": ["10.1089/fpd.2019.2751", "31985261"]}, {"Citation": "Fancello F., Petretto G.L., Marceddu S., Venditti T., Pintore G., Zara G., Mannazzu I., Budroni M., Zara S. Antimicrobial activity of gaseous Citrus limon var pompia leaf essential oil against Listeria monocytogenes on ricotta salata cheese. Food Microbiol. 2020;87:103386. doi: 10.1016/j.fm.2019.103386.", "ArticleIdList": ["10.1016/j.fm.2019.103386", "31948627"]}, {"Citation": "de Souza R.C., da Costa M.M., Baldisserotto B., Heinzmann B.M., Schmidt D., Caron B.O., Copatti C.E. Antimicrobial and synergistic activity of essential oils of Aloysia triphylla and Lippia alba against Aeromonas spp. Microb. Pathog. 2017;113:29\u201333. doi: 10.1016/j.micpath.2017.10.013.", "ArticleIdList": ["10.1016/j.micpath.2017.10.013", "29038058"]}, {"Citation": "Adil M., Baig M.H., Rupasinghe H.P.V. Impact of Citral and Phloretin, Alone and in Combination, on Major Virulence Traits of Streptococcus pyogenes. Molecules. 2019;24:4237. doi: 10.3390/molecules24234237.", "ArticleIdList": ["10.3390/molecules24234237", "PMC6930587", "31766432"]}, {"Citation": "Lulekal E., Tesfaye S., Gebrechristos S., Dires K., Zenebe T., Zegeye N., Feleke G., Kassahun A., Shiferaw Y., Mekonnen A. Phytochemical analysis and evaluation of skin irritation, acute and sub-acute toxicity of Cymbopogon citratus essential oil in mice and rabbits. Toxicol. Rep. 2019;6:1289\u20131294. doi: 10.1016/j.toxrep.2019.11.002.", "ArticleIdList": ["10.1016/j.toxrep.2019.11.002", "PMC6906703", "31867219"]}, {"Citation": "Sharma S., Gupta J., Habib S., Sahu D. Chemical properties and therapeutic potential of citral, a monoterpene isolated from lemongrass. Med. Chem. 2019 doi: 10.2174/1573406416666191227111106.", "ArticleIdList": ["10.2174/1573406416666191227111106", "31880247"]}, {"Citation": "Shen Y., Sun Z., Guo X. Citral inhibits lipopolysaccharide-induced acute lung injury by activating PPAR-gamma. Eur. J. Pharmacol. 2015;747:45\u201351. doi: 10.1016/j.ejphar.2014.09.040.", "ArticleIdList": ["10.1016/j.ejphar.2014.09.040", "25281205"]}, {"Citation": "Boukhatem M.N., Ferhat M.A., Kameli A., Saidi F., Kebir H.T. Lemon grass (Cymbopogon citratus) essential oil as a potent anti-inflammatory and antifungal drugs. Libyan J. Med. 2014;9:25431. doi: 10.3402/ljm.v9.25431.", "ArticleIdList": ["10.3402/ljm.v9.25431", "PMC4170112", "25242268"]}, {"Citation": "Yang S.M., Hua K.F., Lin Y.C., Chen A., Chang J.M., Kuoping Chao L., Ho C.L., Ka S.M. Citral is renoprotective for focal segmental glomerulosclerosis by inhibiting oxidative stress and apoptosis and activating Nrf2 pathway in mice. PLoS ONE. 2013;8:e74871. doi: 10.1371/journal.pone.0074871.", "ArticleIdList": ["10.1371/journal.pone.0074871", "PMC3775727", "24069362"]}, {"Citation": "Campos C.A., Lima B.S., Trindade G.G.G., Souza E., Mota D.S.A., Heimfarth L., Quintans J.S.S., Quintans-Junior L.J., Sussuchi E.M., Sarmento V.H.V., et al. Anti-hyperalgesic and anti-inflammatory effects of citral with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin inclusion complexes in animal models. Life Sci. 2019;229:139\u2013148. doi: 10.1016/j.lfs.2019.05.026.", "ArticleIdList": ["10.1016/j.lfs.2019.05.026", "31085246"]}, {"Citation": "Song Y., Zhao H., Liu J., Fang C., Miao R. Effects of Citral on Lipopolysaccharide-Induced Inflammation in Human Umbilical Vein Endothelial Cells. Inflammation. 2016;39:663\u2013671. doi: 10.1007/s10753-015-0292-0.", "ArticleIdList": ["10.1007/s10753-015-0292-0", "26658749"]}, {"Citation": "Katsukawa M., Nakata R., Takizawa Y., Hori K., Takahashi S., Inoue H. Citral, a component of lemongrass oil, activates PPARalpha and gamma and suppresses COX-2 expression. Biochim. Biophys. Acta. 2010;1801:1214\u20131220. doi: 10.1016/j.bbalip.2010.07.004.", "ArticleIdList": ["10.1016/j.bbalip.2010.07.004", "20656057"]}, {"Citation": "Goncalves E.C.D., Assis P.M., Junqueira L.A., Cola M., Santos A.R.S., Raposo N.R.B., Dutra R.C. Citral Inhibits the Inflammatory Response and Hyperalgesia in Mice: The Role of TLR4, TLR2/Dectin-1, and CB2 Cannabinoid Receptor/ATP-Sensitive K(+) Channel Pathways. J. Nat. Prod. 2020 doi: 10.1021/acs.jnatprod.9b01134.", "ArticleIdList": ["10.1021/acs.jnatprod.9b01134", "32150408"]}, {"Citation": "Bouzenna H., Hfaiedh N., Giroux-Metges M.A., Elfeki A., Talarmin H. Biological properties of citral and its potential protective effects against cytotoxicity caused by aspirin in the IEC-6 cells. Biomed. Pharmacother. 2017;87:653\u2013660. doi: 10.1016/j.biopha.2016.12.104.", "ArticleIdList": ["10.1016/j.biopha.2016.12.104", "28088731"]}, {"Citation": "Ortiz M.I., Ramirez-Montiel M.L., Gonzalez-Garcia M.P., Ponce-Monter H.A., Castaneda-Hernandez G., Carino-Cortes R. The combination of naproxen and citral reduces nociception and gastric damage in rats. Arch. Pharmacal Res. 2010;33:1691\u20131697. doi: 10.1007/s12272-010-1020-9.", "ArticleIdList": ["10.1007/s12272-010-1020-9", "21052946"]}, {"Citation": "Sanches L.J., Marinello P.C., Panis C., Fagundes T.R., Morgado-Diaz J.A., de-Freitas-Junior J.C., Cecchini R., Cecchini A.L., Luiz R.C. Cytotoxicity of citral against melanoma cells: The involvement of oxidative stress generation and cell growth protein reduction. Tumour Biol. J. Int. Soc. Oncodev. Biol. Med. 2017:39. doi: 10.1177/1010428317695914.", "ArticleIdList": ["10.1177/1010428317695914", "28351318"]}, {"Citation": "Sheikh B.Y., Sarker M.M.R., Kamarudin M.N.A., Mohan G. Antiproliferative and apoptosis inducing effects of citral via p53 and ROS-induced mitochondrial-mediated apoptosis in human colorectal HCT116 and HT29 cell lines. Biomed. Pharmacother. 2017;96:834\u2013846. doi: 10.1016/j.biopha.2017.10.038.", "ArticleIdList": ["10.1016/j.biopha.2017.10.038", "29078261"]}, {"Citation": "Nordin N., Yeap S.K., Rahman H.S., Zamberi N.R., Abu N., Mohamad N.E., How C.W., Masarudin M.J., Abdullah R., Alitheen N.B. In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells. Sci. Rep. 2019;9:1614. doi: 10.1038/s41598-018-38214-x.", "ArticleIdList": ["10.1038/s41598-018-38214-x", "PMC6367486", "30733560"]}, {"Citation": "Bayala B., Bassole I.H.N., Maqdasy S., Baron S., Simpore J., Lobaccaro J.A. Cymbopogon citratus and Cymbopogon giganteus essential oils have cytotoxic effects on tumor cell cultures. Identification of citral as a new putative anti-proliferative molecule. Biochimie. 2018;153:162\u2013170. doi: 10.1016/j.biochi.2018.02.013.", "ArticleIdList": ["10.1016/j.biochi.2018.02.013", "29501481"]}, {"Citation": "Zielinska A., Martins-Gomes C., Ferreira N.R., Silva A.M., Nowak I., Souto E.B. Anti-inflammatory and anti-cancer activity of citral: Optimization of citral-loaded solid lipid nanoparticles (SLN) using experimental factorial design and LUMiSizer(R) Int. J. Pharm. 2018;553:428\u2013440. doi: 10.1016/j.ijpharm.2018.10.065.", "ArticleIdList": ["10.1016/j.ijpharm.2018.10.065", "30385373"]}, {"Citation": "Naz F., Khan F.I., Mohammad T., Khan P., Manzoor S., Hasan G.M., Lobb K.A., Luqman S., Islam A., Ahmad F., et al. Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression. Pt BInt. J. Biol. Macromol. 2018;107:2580\u20132589. doi: 10.1016/j.ijbiomac.2017.10.143.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.10.143", "29079437"]}, {"Citation": "Voura M., Khan P., Thysiadis S., Katsamakas S., Queen A., Hasan G.M., Ali S., Sarli V., Hassan M.I. Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones. Sci. Rep. 2019;9:1676. doi: 10.1038/s41598-018-38217-8.", "ArticleIdList": ["10.1038/s41598-018-38217-8", "PMC6368574", "30737440"]}, {"Citation": "Nigjeh S.E., Yeap S.K., Nordin N., Rahman H., Rosli R. In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity. Molecules. 2019;24:3241. doi: 10.3390/molecules24183241.", "ArticleIdList": ["10.3390/molecules24183241", "PMC6767168", "31492037"]}, {"Citation": "Dinavahi S.S., Bazewicz C.G., Gowda R., Robertson G.P. Aldehyde Dehydrogenase Inhibitors for Cancer Therapeutics. Trends Pharmacol. Sci. 2019;40:774\u2013789. doi: 10.1016/j.tips.2019.08.002.", "ArticleIdList": ["10.1016/j.tips.2019.08.002", "31515079"]}, {"Citation": "Thomas M.L., de Antueno R., Coyle K.M., Sultan M., Cruickshank B.M., Giacomantonio M.A., Giacomantonio C.A., Duncan R., Marcato P. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3. Mol. Oncol. 2016;10:1485\u20131496. doi: 10.1016/j.molonc.2016.08.004.", "ArticleIdList": ["10.1016/j.molonc.2016.08.004", "PMC5423215", "27592281"]}, {"Citation": "Nordin N., Yeap S.K., Zamberi N.R., Abu N., Mohamad N.E., Rahman H.S., How C.W., Masarudin M.J., Abdullah R., Alitheen N.B. Characterization and toxicity of citral incorporated with nanostructured lipid carrier. PeerJ. 2018;6:e3916. doi: 10.7717/peerj.3916.", "ArticleIdList": ["10.7717/peerj.3916", "PMC5756616", "29312812"]}, {"Citation": "Maruoka T., Kitanaka A., Kubota Y., Yamaoka G., Kameda T., Imataki O., Dobashi H., Bandoh S., Kadowaki N., Tanaka T. Lemongrass essential oil and citral inhibit Src/Stat3 activity and suppress the proliferation/survival of small-cell lung cancer cells, alone or in combination with chemotherapeutic agents. Int. J. Oncol. 2018;52:1738\u20131748. doi: 10.3892/ijo.2018.4314.", "ArticleIdList": ["10.3892/ijo.2018.4314", "29568932"]}, {"Citation": "Fang Z., Wang Y., Li H., Yu S., Liu Z., Fan Z., Chen X., Wu Y., Pan X., Li X., et al. Combination Treatment of Citral Potentiates the Efficacy of Hyperthermic Intraperitoneal Chemoperfusion with Pirarubicin for Colorectal Cancer. Mol. Pharm. 2017;14:3588\u20133597. doi: 10.1021/acs.molpharmaceut.7b00652.", "ArticleIdList": ["10.1021/acs.molpharmaceut.7b00652", "28841022"]}, {"Citation": "Kremer J.L., Melo G.P., Marinello P.C., Bordini H.P., Rossaneis A.C., Sabio L.R., Cecchini R., Cecchini A.L., Verri W.A., Jr., Luiz R.C. Citral prevents UVB-induced skin carcinogenesis in hairless mice. J. Photochem. Photobiol. Biol. 2019;198:111565. doi: 10.1016/j.jphotobiol.2019.111565.", "ArticleIdList": ["10.1016/j.jphotobiol.2019.111565", "31374350"]}, {"Citation": "Venkatesha S.H., Moudgil K.D. Celastrol and Its Role in Controlling Chronic Diseases. Adv. Exp. Med. Biol. 2016;928:267\u2013289.", "ArticleIdList": ["PMC8056454", "27671821"]}, {"Citation": "Law S., Leung A.W., Xu C. Folic acid-modified celastrol nanoparticles: Synthesis, characterization, anticancer activity in 2D and 3D breast cancer models. Artif. Cells Nanomed. Biotechnol. 2020;48:542\u2013559. doi: 10.1080/21691401.2020.1725025.", "ArticleIdList": ["10.1080/21691401.2020.1725025", "32054336"]}, {"Citation": "Zhu B., Wei Y. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway. Cancer Med. 2020;9:783\u2013796. doi: 10.1002/cam4.2719.", "ArticleIdList": ["10.1002/cam4.2719", "PMC6970044", "31957323"]}, {"Citation": "Allison A.C., Cacabelos R., Lombardi V.R., Alvarez X.A., Vigo C. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer\u2019s disease. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2001;25:1341\u20131357. doi: 10.1016/S0278-5846(01)00192-0.", "ArticleIdList": ["10.1016/S0278-5846(01)00192-0", "11513350"]}, {"Citation": "Wang H., Ahn K.S., Alharbi S.A., Shair O.H., Arfuso F., Sethi G., Chinnathambi A., Tang F.R. Celastrol Alleviates Gamma Irradiation-Induced Damage by Modulating Diverse Inflammatory Mediators. Int. J. Mol. Sci. 2020;21:1084. doi: 10.3390/ijms21031084.", "ArticleIdList": ["10.3390/ijms21031084", "PMC7036880", "32041250"]}, {"Citation": "Kim D.H., Shin E.K., Kim Y.H., Lee B.W., Jun J.G., Park J.H., Kim J.K. Suppression of inflammatory responses by celastrol, a quinone methide triterpenoid isolated from Celastrus regelii. Eur. J. Clin. Investig. 2009;39:819\u2013827. doi: 10.1111/j.1365-2362.2009.02186.x.", "ArticleIdList": ["10.1111/j.1365-2362.2009.02186.x", "19549173"]}, {"Citation": "Venkatesha S.H., Yu H., Rajaiah R., Tong L., Moudgil K.D. Celastrus-derived celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responses. J. Biol. Chem. 2011;286:15138\u201315146. doi: 10.1074/jbc.M111.226365.", "ArticleIdList": ["10.1074/jbc.M111.226365", "PMC3083183", "21402700"]}, {"Citation": "Li H., Yuan Y., Zhang Y., He Q., Xu R., Ge F., Wu C. Celastrol inhibits IL-1beta-induced inflammation in orbital fibroblasts through the suppression of NF-\u03baB activity. Mol. Med. Rep. 2016;14:2799\u20132806. doi: 10.3892/mmr.2016.5570.", "ArticleIdList": ["10.3892/mmr.2016.5570", "27484716"]}, {"Citation": "Paris D., Ganey N.J., Laporte V., Patel N.S., Beaulieu-Abdelahad D., Bachmeier C., March A., Ait-Ghezala G., Mullan M.J. Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer\u2019s disease. J. Neuroinflamm. 2010;7:17. doi: 10.1186/1742-2094-7-17.", "ArticleIdList": ["10.1186/1742-2094-7-17", "PMC2841120", "20211007"]}, {"Citation": "Shrivastava S., Jeengar M.K., Reddy V.S., Reddy G.B., Naidu V.G. Anticancer effect of celastrol on human triple negative breast cancer: Possible involvement of oxidative stress, mitochondrial dysfunction, apoptosis and PI3K/Akt pathways. Exp. Mol. Pathol. 2015;98:313\u2013327. doi: 10.1016/j.yexmp.2015.03.031.", "ArticleIdList": ["10.1016/j.yexmp.2015.03.031", "25818165"]}, {"Citation": "Nagase M., Oto J., Sugiyama S., Yube K., Takaishi Y., Sakato N. Apoptosis induction in HL-60 cells and inhibition of topoisomerase II by triterpene celastrol. Biosci. Biotechnol. Biochem. 2003;67:1883\u20131887. doi: 10.1271/bbb.67.1883.", "ArticleIdList": ["10.1271/bbb.67.1883", "14519971"]}, {"Citation": "Yu X., Ruan X., Zhang J., Zhao Q. Celastrol Induces Cell Apoptosis and Inhibits the Expression of the AML1-ETO/C-KIT Oncoprotein in t(8;21) Leukemia. Molecules. 2016;21:574. doi: 10.3390/molecules21050574.", "ArticleIdList": ["10.3390/molecules21050574", "PMC6274014", "27144550"]}, {"Citation": "Hsieh M.J., Wang C.W., Lin J.T., Chuang Y.C., Hsi Y.T., Lo Y.S., Lin C.C., Chen M.K. Celastrol, a plant-derived triterpene, induces cisplatin-resistance nasopharyngeal carcinoma cancer cell apoptosis though ERK1/2 and p38 MAPK signaling pathway. Phytomed. Int. J. Phytother. Phytopharm. 2019;58:152805. doi: 10.1016/j.phymed.2018.12.028.", "ArticleIdList": ["10.1016/j.phymed.2018.12.028", "31022663"]}, {"Citation": "Liu Z., Ma L., Wen Z.S., Hu Z., Wu F.Q., Li W., Liu J., Zhou G.B. Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer. Carcinogenesis. 2014;35:905\u2013914. doi: 10.1093/carcin/bgt395.", "ArticleIdList": ["10.1093/carcin/bgt395", "PMC4319067", "24293411"]}, {"Citation": "Kannaiyan R., Manu K.A., Chen L., Li F., Rajendran P., Subramaniam A., Lam P., Kumar A.P., Sethi G. Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways. Apoptosis: Int. J. Program. Cell Death. 2011;16:1028\u20131041. doi: 10.1007/s10495-011-0629-6.", "ArticleIdList": ["10.1007/s10495-011-0629-6", "21786165"]}, {"Citation": "Kiaei M., Kipiani K., Petri S., Chen J., Calingasan N.Y., Beal M.F. Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neuro-Degener. Dis. 2005;2:246\u2013254. doi: 10.1159/000090364.", "ArticleIdList": ["10.1159/000090364", "16909005"]}, {"Citation": "Chow A.M., Tang D.W., Hanif A., Brown I.R. Localization of heat shock proteins in cerebral cortical cultures following induction by celastrol. Cell Stress Chaperones. 2014;19:845\u2013851. doi: 10.1007/s12192-014-0508-5.", "ArticleIdList": ["10.1007/s12192-014-0508-5", "PMC4389844", "24700193"]}, {"Citation": "Hou W., Liu B., Xu H. Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology. Eur. J. Med. Chem. 2020;189:112081. doi: 10.1016/j.ejmech.2020.112081.", "ArticleIdList": ["10.1016/j.ejmech.2020.112081", "31991334"]}, {"Citation": "Leonti M., Casu L., Raduner S., Cottiglia F., Floris C., Altmann K.H., Gertsch J. Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin. Biochem. Pharmacol. 2010;79:1815\u20131826. doi: 10.1016/j.bcp.2010.02.015.", "ArticleIdList": ["10.1016/j.bcp.2010.02.015", "20206138"]}, {"Citation": "Kobaek-Larsen M., Nielsen D.S., Kot W., Krych L., Christensen L.P., Baatrup G. Effect of the dietary polyacetylenes falcarinol and falcarindiol on the gut microbiota composition in a rat model of colorectal cancer. BMC Res. Notes. 2018;11:411. doi: 10.1186/s13104-018-3527-y.", "ArticleIdList": ["10.1186/s13104-018-3527-y", "PMC6020439", "29945666"]}, {"Citation": "Stefanson A.L., Bakovic M. Falcarinol Is a Potent Inducer of Heme Oxygenase-1 and Was More Effective than Sulforaphane in Attenuating Intestinal Inflammation at Diet-Achievable Doses. Oxidative Med. Cell. Longev. 2018;2018:3153527. doi: 10.1155/2018/3153527.", "ArticleIdList": ["10.1155/2018/3153527", "PMC6215554", "30420908"]}, {"Citation": "Yamauchi T., Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int. J. Obes. 2008;32(Suppl. 7):S13\u2013S18. doi: 10.1038/ijo.2008.233.", "ArticleIdList": ["10.1038/ijo.2008.233", "19136982"]}, {"Citation": "Takagi M., Kimura K., Nakashima K.I., Inoue M. Ameliorative effect of panaxynol on the reduction in high-molecular-weight adiponectin secretion from 3T3-L1 adipocytes treated with palmitic acids. Eur. J. Pharmacol. 2018;820:138\u2013145. doi: 10.1016/j.ejphar.2017.12.028.", "ArticleIdList": ["10.1016/j.ejphar.2017.12.028", "29248425"]}, {"Citation": "Yu L.C. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: Exploring a common ground hypothesis. J. Biomed. Sci. 2018;25:79. doi: 10.1186/s12929-018-0483-8.", "ArticleIdList": ["10.1186/s12929-018-0483-8", "PMC6234774", "30413188"]}, {"Citation": "Kho Z.Y., Lal S.K. The Human Gut Microbiome\u2014A Potential Controller of Wellness and Disease. Front. Microbiol. 2018;9:1835. doi: 10.3389/fmicb.2018.01835.", "ArticleIdList": ["10.3389/fmicb.2018.01835", "PMC6102370", "30154767"]}, {"Citation": "Kobaek-Larsen M., El-Houri R.B., Christensen L.P., Al-Najami I., Frette X., Baatrup G. Dietary polyacetylenes, falcarinol and falcarindiol, isolated from carrots prevents the formation of neoplastic lesions in the colon of azoxymethane-induced rats. Food Funct. 2017;8:964\u2013974. doi: 10.1039/C7FO00110J.", "ArticleIdList": ["10.1039/C7FO00110J", "28197615"]}, {"Citation": "Kobaek-Larsen M., Baatrup G., KhataeiNotabi M., El-Houri R.B., Pipo-Olle E., Christensen Arnspang E., Christensen L.P. Dietary Polyacetylenic Oxylipins Falcarinol and Falcarindiol Prevent Inflammation and Colorectal Neoplastic Transformation: A Mechanistic and Dose-Response Study in A Rat Model. Nutrients. 2019;11:2223. doi: 10.3390/nu11092223.", "ArticleIdList": ["10.3390/nu11092223", "PMC6769548", "31540047"]}, {"Citation": "Moharil R.B., Dive A., Khandekar S., Bodhade A. Cancer stem cells: An insight. J. Oral Maxillofac. Pathol. JOMFP. 2017;21:463. doi: 10.4103/jomfp.JOMFP_132_16.", "ArticleIdList": ["10.4103/jomfp.JOMFP_132_16", "PMC5763886", "29391738"]}, {"Citation": "Zappa C., Mousa S.A. Non-small cell lung cancer: Current treatment and future advances. Transl. Lung Cancer Res. 2016;5:288\u2013300. doi: 10.21037/tlcr.2016.06.07.", "ArticleIdList": ["10.21037/tlcr.2016.06.07", "PMC4931124", "27413711"]}, {"Citation": "Trepel J., Mollapour M., Giaccone G., Neckers L. Targeting the dynamic HSP90 complex in cancer. Nat. Rev. Cancer. 2010;10:537\u2013549. doi: 10.1038/nrc2887.", "ArticleIdList": ["10.1038/nrc2887", "PMC6778733", "20651736"]}, {"Citation": "Yan Z., Yang R., Jiang Y., Yang Z., Yang J., Zhao Q., Lu Y. Induction of apoptosis in human promyelocytic leukemia HL60 cells by panaxynol and panaxydol. Molecules. 2011;16:5561\u20135573. doi: 10.3390/molecules16075561.", "ArticleIdList": ["10.3390/molecules16075561", "PMC6264185", "21716177"]}, {"Citation": "Henderson S.K., Cohen H. Nalbuphine augmentation of analgesia and reversal of side effects following epidural hydromorphone. Anesthesiology. 1986;65:216\u2013218. doi: 10.1097/00000542-198608000-00017.", "ArticleIdList": ["10.1097/00000542-198608000-00017", "2426995"]}, {"Citation": "Wang Z.J., Song L., Guo L.C., Yin M., Sun Y.N. Induction of differentiation by panaxydol in human hepatocarcinoma SMMC-7721 cells via cAMP and MAP kinase dependent mechanism. Yakugaku Zasshi: J. Pharm. Soc. Jpn. 2011;131:993\u20131000. doi: 10.1248/yakushi.131.993.", "ArticleIdList": ["10.1248/yakushi.131.993", "21628989"]}, {"Citation": "Sohn J., Lee C.H., Chung D.J., Park S.H., Kim I., Hwang W.I. Effect of petroleum ether extract of Panax ginseng roots on proliferation and cell cycle progression of human renal cell carcinoma cells. Exp. Mol. Med. 1998;30:47\u201351. doi: 10.1038/emm.1998.7.", "ArticleIdList": ["10.1038/emm.1998.7", "9873822"]}, {"Citation": "Hai J., Lin Q., Lu Y., Yi J., Zhang H. Growth inhibition and induction of differentiation by panaxydol in rat C6 glioma cells. Neurol. Res. 2008;30:99\u2013105. doi: 10.1179/016164107X228697.", "ArticleIdList": ["10.1179/016164107X228697", "17767808"]}, {"Citation": "Machado S., Silva E., Massa A. Occupational allergic contact dermatitis from falcarinol. Contact Dermat. 2002;47:113\u2013114. doi: 10.1034/j.1600-0536.2002.470210_5.x.", "ArticleIdList": ["10.1034/j.1600-0536.2002.470210_5.x", "12423414"]}, {"Citation": "Qu C., Li B., Lai Y., Li H., Windust A., Hofseth L.J., Nagarkatti M., Nagarkatti P., Wang X.L., Tang D., et al. Identifying panaxynol, a natural activator of nuclear factor erythroid-2 related factor 2 (Nrf2) from American ginseng as a suppressor of inflamed macrophage-induced cardiomyocyte hypertrophy. J. Ethnopharmacol. 2015;168:326\u2013336. doi: 10.1016/j.jep.2015.04.004.", "ArticleIdList": ["10.1016/j.jep.2015.04.004", "PMC4810680", "25882312"]}, {"Citation": "Phinney S.D., Tang A.B., Waggoner C.R., Tezanos-Pinto R.G., Davis P.A. The transient hypercholesterolemia of major weight loss. Am. J. Clin. Nutr. 1991;53:1404\u20131410. doi: 10.1093/ajcn/53.6.1404.", "ArticleIdList": ["10.1093/ajcn/53.6.1404", "2035468"]}, {"Citation": "MacLean K.A., Johnson M.W., Reissig C.J., Prisinzano T.E., Griffiths R.R. Dose-related effects of salvinorin A in humans: Dissociative, hallucinogenic, and memory effects. Psychopharmacology. 2013;226:381\u2013392. doi: 10.1007/s00213-012-2912-9.", "ArticleIdList": ["10.1007/s00213-012-2912-9", "PMC3581702", "23135605"]}, {"Citation": "Roach J.J., Shenvi R.A. A review of salvinorin analogs and their kappa-opioid receptor activity. Bioorganic Med. Chem. Lett. 2018;28:1436\u20131445. doi: 10.1016/j.bmcl.2018.03.029.", "ArticleIdList": ["10.1016/j.bmcl.2018.03.029", "PMC5912166", "29615341"]}, {"Citation": "Walentiny D.M., Vann R.E., Warner J.A., King L.S., Seltzman H.H., Navarro H.A., Twine C.E., Jr., Thomas B.F., Gilliam A.F., Gilmour B.P., et al. Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents. Psychopharmacology. 2010;210:275\u2013284. doi: 10.1007/s00213-010-1827-6.", "ArticleIdList": ["10.1007/s00213-010-1827-6", "PMC3013230", "20354680"]}, {"Citation": "Coffeen U., Canseco-Alba A., Simon-Arceo K., Almanza A., Mercado F., Leon-Olea M., Pellicer F. Salvinorin A reduces neuropathic nociception in the insular cortex of the rat. Eur. J. Pain. 2018;22:311\u2013318. doi: 10.1002/ejp.1120.", "ArticleIdList": ["10.1002/ejp.1120", "28975684"]}, {"Citation": "Guida F., Luongo L., Aviello G., Palazzo E., De Chiaro M., Gatta L., Boccella S., Marabese I., Zjawiony J.K., Capasso R., et al. Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection. Mol. Pain. 2012;8:60. doi: 10.1186/1744-8069-8-60.", "ArticleIdList": ["10.1186/1744-8069-8-60", "PMC3522567", "22913292"]}, {"Citation": "Butelman E.R., Prisinzano T.E., Deng H., Rus S., Kreek M.J. Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: Fast onset and entry into cerebrospinal fluid. J. Pharmacol. Exp. Ther. 2009;328:588\u2013597. doi: 10.1124/jpet.108.145342.", "ArticleIdList": ["10.1124/jpet.108.145342", "PMC2682281", "19001155"]}, {"Citation": "Prisinzano T.E. Psychopharmacology of the hallucinogenic sage Salvia divinorum. Life Sci. 2005;78:527\u2013531. doi: 10.1016/j.lfs.2005.09.008.", "ArticleIdList": ["10.1016/j.lfs.2005.09.008", "16213533"]}, {"Citation": "Ranganathan M., Schnakenberg A., Skosnik P.D., Cohen B.M., Pittman B., Sewell R.A., D\u2019Souza D.C. Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the kappa opioid agonist Salvinorin A in humans. Biol. Psychiatry. 2012;72:871\u2013879. doi: 10.1016/j.biopsych.2012.06.012.", "ArticleIdList": ["10.1016/j.biopsych.2012.06.012", "PMC3638802", "22817868"]}, {"Citation": "Paton K.F., Kumar N., Crowley R.S., Harper J.L., Prisinzano T.E., Kivell B.M. The analgesic and anti-inflammatory effects of Salvinorin A analogue beta-tetrahydropyran Salvinorin B in mice. Eur. J. Pain. 2017;21:1039\u20131050. doi: 10.1002/ejp.1002.", "ArticleIdList": ["10.1002/ejp.1002", "PMC5466480", "28158929"]}, {"Citation": "Kivell B.M., Paton K.F., Kumar N., Morani A.S., Culverhouse A., Shepherd A., Welsh S.A., Biggerstaff A., Crowley R.S., Prisinzano T.E. Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents. Molecules. 2018;23:2602. doi: 10.3390/molecules23102602.", "ArticleIdList": ["10.3390/molecules23102602", "PMC6222496", "30314288"]}, {"Citation": "Zhou Y., Crowley R., Prisinzano T., Kreek M.J. Effects of mesyl salvinorin B alone and in combination with naltrexone on alcohol deprivation effect in male and female mice. Neurosci. Lett. 2018;673:19\u201323. doi: 10.1016/j.neulet.2018.02.056.", "ArticleIdList": ["10.1016/j.neulet.2018.02.056", "PMC6293468", "29496608"]}, {"Citation": "Salaga M., Polepally P.R., Zakrzewski P.K., Cygankiewicz A., Sobczak M., Kordek R., Zjawiony J.K., Krajewska W.M., Fichna J. Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors. Biochem. Pharmacol. 2014;92:618\u2013626. doi: 10.1016/j.bcp.2014.09.018.", "ArticleIdList": ["10.1016/j.bcp.2014.09.018", "25265540"]}, {"Citation": "Wang Z., Ma N., Riley J., Armstead W.M., Liu R. Salvinorin A administration after global cerebral hypoxia/ischemia preserves cerebrovascular autoregulation via kappa opioid receptor in piglets. PLoS ONE. 2012;7:e41724. doi: 10.1371/journal.pone.0041724.", "ArticleIdList": ["10.1371/journal.pone.0041724", "PMC3404042", "22911847"]}, {"Citation": "Su D., Riley J., Armstead W.M., Liu R. Salvinorin A pretreatment preserves cerebrovascular autoregulation after brain hypoxic/ischemic injury via extracellular signal-regulated kinase/mitogen-activated protein kinase in piglets. Anesth. Analg. 2012;114:200\u2013204. doi: 10.1213/ANE.0b013e31823a5d36.", "ArticleIdList": ["10.1213/ANE.0b013e31823a5d36", "PMC3292782", "22075021"]}, {"Citation": "Xin J., Zhang Y., He Z., Wang Z. Highly selective non-opioid kappa opioid receptor (KOR) agonist salvinorin A protects against forebrain ischemia-induced brain injury in rats. Brain Res. 2016;1637:168\u2013176. doi: 10.1016/j.brainres.2016.02.024.", "ArticleIdList": ["10.1016/j.brainres.2016.02.024", "26907190"]}, {"Citation": "Sun J., Zhang Y., Lu J., Zhang W., Yan J., Yang L., Zhou C., Liu R., Chen C. Salvinorin A ameliorates cerebral vasospasm through activation of endothelial nitric oxide synthase in a rat model of subarachnoid hemorrhage. Microcirculation. 2018;25:e12442. doi: 10.1111/micc.12442.", "ArticleIdList": ["10.1111/micc.12442", "29377443"]}, {"Citation": "Dong H., Zhou W., Xin J., Shi H., Yao X., He Z., Wang Z. Salvinorin A moderates postischemic brain injury by preserving endothelial mitochondrial function via AMPK/Mfn2 activation. Exp. Neurol. 2019;322:113045. doi: 10.1016/j.expneurol.2019.113045.", "ArticleIdList": ["10.1016/j.expneurol.2019.113045", "31461637"]}, {"Citation": "Tang G., Yang G.Y. Aquaporin-4: A Potential Therapeutic Target for Cerebral Edema. Int. J. Mol. Sci. 2016;17:1413. doi: 10.3390/ijms17101413.", "ArticleIdList": ["10.3390/ijms17101413", "PMC5085613", "27690011"]}, {"Citation": "Braida D., Capurro V., Zani A., Rubino T., Vigano D., Parolaro D., Sala M. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents. Br. J. Pharmacol. 2009;157:844\u2013853. doi: 10.1111/j.1476-5381.2009.00230.x.", "ArticleIdList": ["10.1111/j.1476-5381.2009.00230.x", "PMC2721268", "19422370"]}, {"Citation": "Ebner S.R., Roitman M.F., Potter D.N., Rachlin A.B., Chartoff E.H. Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens. Psychopharmacology. 2010;210:241\u2013252. doi: 10.1007/s00213-010-1836-5.", "ArticleIdList": ["10.1007/s00213-010-1836-5", "PMC2894632", "20372879"]}, {"Citation": "Kivell B., Uzelac Z., Sundaramurthy S., Rajamanickam J., Ewald A., Chefer V., Jaligam V., Bolan E., Simonson B., Annamalai B., et al. Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology. 2014;86:228\u2013240. doi: 10.1016/j.neuropharm.2014.07.016.", "ArticleIdList": ["10.1016/j.neuropharm.2014.07.016", "PMC4188751", "25107591"]}, {"Citation": "Keasling A.W., Pandey P., Doerksen R.J., Pedrino G.R., Costa E.A., da Cunha L.C., Zjawiony J.K., Fajemiroye J.O. Salvindolin elicits opioid system-mediated antinociceptive and antidepressant-like activities. J. Psychopharmacol. 2019;33:865\u2013881. doi: 10.1177/0269881119849821.", "ArticleIdList": ["10.1177/0269881119849821", "31192780"]}, {"Citation": "Fajemiroye J.O., Prabhakar P.R., Cunha L.C., Costa E.A., Zjawiony J.K. 22-azidosalvinorin A exhibits antidepressant-like effect in mice. Eur. J. Pharmacol. 2017;800:96\u2013106. doi: 10.1016/j.ejphar.2017.02.031.", "ArticleIdList": ["10.1016/j.ejphar.2017.02.031", "28219707"]}, {"Citation": "Rossi A., Caiazzo E., Bilancia R., Riemma M.A., Pagano E., Cicala C., Ialenti A., Zjawiony J.K., Izzo A.A., Capasso R., et al. Salvinorin A Inhibits Airway Hyperreactivity Induced by Ovalbumin Sensitization. Front. Pharmacol. 2016;7:525. doi: 10.3389/fphar.2016.00525.", "ArticleIdList": ["10.3389/fphar.2016.00525", "PMC5233683", "28133450"]}, {"Citation": "Salaga M., Polepally P.R., Zielinska M., Marynowski M., Fabisiak A., Murawska N., Sobczak K., Sacharczuk M., Do Rego J.C., Roth B.L., et al. Salvinorin A analogues PR-37 and PR-38 attenuate compound 48/80-induced itch responses in mice. Br. J. Pharmacol. 2015;172:4331\u20134341. doi: 10.1111/bph.13212.", "ArticleIdList": ["10.1111/bph.13212", "PMC4556471", "26040667"]}, {"Citation": "Gertsch J., Pertwee R.G., Di Marzo V. Phytocannabinoids beyond the Cannabis plant\u2014Do they exist? Br. J. Pharmacol. 2010;160:523\u2013529. doi: 10.1111/j.1476-5381.2010.00745.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.00745.x", "PMC2931553", "20590562"]}, {"Citation": "Zhao Q., Bi Y., Zhong J., Ren Z., Liu Y., Jia J., Yu M., Tan Y., Zhang Q., Yu X. Pristimerin suppresses colorectal cancer through inhibiting inflammatory responses and Wnt/beta-catenin signaling. Toxicol. Appl. Pharmacol. 2020;386:114813. doi: 10.1016/j.taap.2019.114813.", "ArticleIdList": ["10.1016/j.taap.2019.114813", "31715269"]}, {"Citation": "Yousef B.A., Hassan H.M., Zhang L.Y., Jiang Z.Z. Pristimerin exhibits in vitro and in vivo anticancer activities through inhibition of nuclear factor-small ka, CyrillicB signaling pathway in colorectal cancer cells. Phytomed. Int. J. Phytother. Phytopharm. 2018;40:140\u2013147.", "ArticleIdList": ["29496166"]}, {"Citation": "Slattery M.L., Mullany L.E., Sakoda L., Samowitz W.S., Wolff R.K., Stevens J.R., Herrick J.S. The NF-\u03baB signalling pathway in colorectal cancer: Associations between dysregulated gene and miRNA expression. J. Cancer Res. Clin. Oncol. 2018;144:269\u2013283. doi: 10.1007/s00432-017-2548-6.", "ArticleIdList": ["10.1007/s00432-017-2548-6", "PMC5794831", "29188362"]}, {"Citation": "Park J.H., Kim J.K. Pristimerin, a naturally occurring triterpenoid, attenuates tumorigenesis in experimental colitis-associated colon cancer. Phytomed. Int. J. Phytother. Phytopharm. 2018;42:164\u2013171. doi: 10.1016/j.phymed.2018.03.033.", "ArticleIdList": ["10.1016/j.phymed.2018.03.033", "29655682"]}, {"Citation": "Grossi V., Fasano C., Celestini V., Lepore Signorile M., Sanese P., Simone C. Chasing the FOXO3: Insights into Its New Mitochondrial Lair in Colorectal Cancer Landscape. Cancers. 2019;11:414. doi: 10.3390/cancers11030414.", "ArticleIdList": ["10.3390/cancers11030414", "PMC6468785", "30909600"]}, {"Citation": "Liu Y., Ao X., Ding W., Ponnusamy M., Wu W., Hao X., Yu W., Wang Y., Li P., Wang J. Critical role of FOXO3a in carcinogenesis. Mol. Cancer. 2018;17:104. doi: 10.1186/s12943-018-0856-3.", "ArticleIdList": ["10.1186/s12943-018-0856-3", "PMC6060507", "30045773"]}, {"Citation": "Yousef B.A., Hassan H.M., Guerram M., Hamdi A.M., Wang B., Zhang L.Y., Jiang Z.Z. Pristimerin inhibits proliferation, migration and invasion, and induces apoptosis in HCT-116 colorectal cancer cells. Biomed. Pharmacother. 2016;79:112\u2013119. doi: 10.1016/j.biopha.2016.02.003.", "ArticleIdList": ["10.1016/j.biopha.2016.02.003", "27044819"]}, {"Citation": "Yousef B.A., Guerram M., Hassan H.M., Hamdi A.M., Zhang L.Y., Jiang Z.Z. Pristimerin demonstrates anticancer potential in colorectal cancer cells by inducing G1 phase arrest and apoptosis and suppressing various pro-survival signaling proteins. Oncol. Rep. 2016;35:1091\u20131100. doi: 10.3892/or.2015.4457.", "ArticleIdList": ["10.3892/or.2015.4457", "26718323"]}, {"Citation": "Adams R., Brown E., Brown L., Butler R., Falk S., Fisher D., Kaplan R., Quirke P., Richman S., Samuel L., et al. Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): A phase 2\u20133 randomised trial. Lancet. Gastroenterol. Hepatol. 2018;3:162\u2013171. doi: 10.1016/S2468-1253(17)30394-1.", "ArticleIdList": ["10.1016/S2468-1253(17)30394-1", "PMC6125825", "29254887"]}, {"Citation": "Zhao Q., Liu Y., Zhong J., Bi Y., Liu Y., Ren Z., Li X., Jia J., Yu M., Yu X. Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo. Cell Death Discov. 2019;5:125. doi: 10.1038/s41420-019-0208-0.", "ArticleIdList": ["10.1038/s41420-019-0208-0", "PMC6680048", "31396402"]}, {"Citation": "Lee Y., Na J., Lee M.S., Cha E.Y., Sul J.Y., Park J.B., Lee J.S. Combination of pristimerin and paclitaxel additively induces autophagy in human breast cancer cells via ERK1/2 regulation. Mol. Med. Rep. 2018;18:4281\u20134288. doi: 10.3892/mmr.2018.9488.", "ArticleIdList": ["10.3892/mmr.2018.9488", "PMC6172393", "30221728"]}, {"Citation": "Cevatemre B., Erkisa M., Aztopal N., Karakas D., Alper P., Tsimplouli C., Sereti E., Dimas K., Armutak E.I.I., Gurevin E.G., et al. A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer. Pharmacol. Res. 2018;129:500\u2013514. doi: 10.1016/j.phrs.2017.11.027.", "ArticleIdList": ["10.1016/j.phrs.2017.11.027", "29197639"]}, {"Citation": "Xie G., Yu X., Liang H., Chen J., Tang X., Wu S., Liao C. Pristimerin overcomes adriamycin resistance in breast cancer cells through suppressing Akt signaling. Oncol. Lett. 2016;11:3111\u20133116. doi: 10.3892/ol.2016.4335.", "ArticleIdList": ["10.3892/ol.2016.4335", "PMC4840996", "27123073"]}, {"Citation": "Lee J.S., Yoon I.S., Lee M.S., Cha E.Y., Thuong P.T., Diep T.T., Kim J.R. Anticancer activity of pristimerin in epidermal growth factor receptor 2-positive SKBR3 human breast cancer cells. Biol. Pharm. Bull. 2013;36:316\u2013325. doi: 10.1248/bpb.b12-00685.", "ArticleIdList": ["10.1248/bpb.b12-00685", "23370361"]}, {"Citation": "Zhang B., Zhang J., Pan J. Pristimerin effectively inhibits the malignant phenotypes of uveal melanoma cells by targeting NFkappaB pathway. Int. J. Oncol. 2017;51:887\u2013898. doi: 10.3892/ijo.2017.4079.", "ArticleIdList": ["10.3892/ijo.2017.4079", "28766683"]}, {"Citation": "Mori Y., Shirai T., Terauchi R., Tsuchida S., Mizoshiri N., Hayashi D., Arai Y., Kishida T., Mazda O., Kubo T. Antitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo. Oncotargets Ther. 2017;10:5703\u20135710. doi: 10.2147/OTT.S150071.", "ArticleIdList": ["10.2147/OTT.S150071", "PMC5713707", "29238202"]}, {"Citation": "Deeb D., Gao X., Liu Y.B., Pindolia K., Gautam S.C. Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-\u03baB/mTOR signaling proteins and anti-apoptotic Bcl-2. Int. J. Oncol. 2014;44:1707\u20131715. doi: 10.3892/ijo.2014.2325.", "ArticleIdList": ["10.3892/ijo.2014.2325", "PMC4027926", "24603988"]}, {"Citation": "Deeb D., Gao X., Liu Y., Pindolia K., Gautam S.C. Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells. Oncol. Rep. 2015;34:518\u2013524. doi: 10.3892/or.2015.3989.", "ArticleIdList": ["10.3892/or.2015.3989", "PMC4484616", "25997419"]}, {"Citation": "Lee S.O., Kim J.S., Lee M.S., Lee H.J. Anti-cancer effect of pristimerin by inhibition of HIF-1alpha involves the SPHK-1 pathway in hypoxic prostate cancer cells. BMC Cancer. 2016;16:701. doi: 10.1186/s12885-016-2730-2.", "ArticleIdList": ["10.1186/s12885-016-2730-2", "PMC5007821", "27581969"]}, {"Citation": "Liu Y.B., Gao X., Deeb D., Pindolia K., Gautam S.C. Role of telomerase in anticancer activity of pristimerin in prostate cancer cells. J. Exp. Ther. Oncol. 2015;11:41\u201349.", "ArticleIdList": ["26259389"]}, {"Citation": "Liu Y.B., Gao X., Deeb D., Brigolin C., Zhang Y., Shaw J., Pindolia K., Gautam S.C. Ubiquitin-proteasomal degradation of antiapoptotic survivin facilitates induction of apoptosis in prostate cancer cells by pristimerin. Int. J. Oncol. 2014;45:1735\u20131741. doi: 10.3892/ijo.2014.2561.", "ArticleIdList": ["10.3892/ijo.2014.2561", "PMC4151800", "25175770"]}, {"Citation": "Liu Y.B., Gao X., Deeb D., Arbab A.S., Gautam S.C. Pristimerin Induces Apoptosis in Prostate Cancer Cells by Down-regulating Bcl-2 through ROS-dependent Ubiquitin-proteasomal Degradation Pathway. J. Carcinog. Mutagenesis. 2013 doi: 10.4172/2157-2518.S6-005.", "ArticleIdList": ["10.4172/2157-2518.S6-005", "PMC4035051", "24877026"]}, {"Citation": "Clark A.R., Toker A. Signalling specificity in the Akt pathway in breast cancer. Biochem. Soc. Trans. 2014;42:1349\u20131355. doi: 10.1042/BST20140160.", "ArticleIdList": ["10.1042/BST20140160", "25233414"]}, {"Citation": "Jin Y., Huynh D.T.N., Kang K.W., Myung C.S., Heo K.S. Inhibition of p90RSK activation sensitizes triple-negative breast cancer cells to cisplatin by inhibiting proliferation, migration and EMT. BMB Rep. 2019;52:706\u2013711. doi: 10.5483/BMBRep.2019.52.12.234.", "ArticleIdList": ["10.5483/BMBRep.2019.52.12.234", "PMC6941763", "31818359"]}, {"Citation": "Li Z., Hu C., Zhen Y., Pang B., Yi H., Chen X. Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p. Biosci. Rep. 2019;39 doi: 10.1042/BSR20182389.", "ArticleIdList": ["10.1042/BSR20182389", "PMC6522714", "31015365"]}, {"Citation": "Ye Z., Jin H., Qian Q. Argonaute 2: A Novel Rising Star in Cancer Research. J. Cancer. 2015;6:877\u2013882. doi: 10.7150/jca.11735.", "ArticleIdList": ["10.7150/jca.11735", "PMC4532985", "26284139"]}, {"Citation": "Liu J., Luan W., Zhang Y., Gu J., Shi Y., Yang Y., Feng Z., Qi F. HDAC6 interacts with PTPN1 to enhance melanoma cells progression. Biochem. Biophys. Res. Commun. 2018;495:2630\u20132636. doi: 10.1016/j.bbrc.2017.12.145.", "ArticleIdList": ["10.1016/j.bbrc.2017.12.145", "29278704"]}, {"Citation": "Zhao H., Wang C., Lu B., Zhou Z., Jin Y., Wang Z., Zheng L., Liu K., Luo T., Zhu D., et al. Pristimerin triggers AIF-dependent programmed necrosis in glioma cells via activation of JNK. Cancer Lett. 2016;374:136\u2013148. doi: 10.1016/j.canlet.2016.01.055.", "ArticleIdList": ["10.1016/j.canlet.2016.01.055", "26854718"]}, {"Citation": "Yan Y.Y., Bai J.P., Xie Y., Yu J.Z., Ma C.G. The triterpenoid pristimerin induces U87 glioma cell apoptosis through reactive oxygen species-mediated mitochondrial dysfunction. Oncol. Lett. 2013;5:242\u2013248. doi: 10.3892/ol.2012.982.", "ArticleIdList": ["10.3892/ol.2012.982", "PMC3525416", "23255929"]}, {"Citation": "Thomas R., Weihua Z. Rethink of EGFR in Cancer with Its Kinase Independent Function on Board. Front. Oncol. 2019;9:800. doi: 10.3389/fonc.2019.00800.", "ArticleIdList": ["10.3389/fonc.2019.00800", "PMC6716122", "31508364"]}, {"Citation": "Wu H., Li L., Ai Z., Yin J., Chen L. Pristimerin induces apoptosis of oral squamous cell carcinoma cells via G1 phase arrest and MAPK/Erk1/2 and Akt signaling inhibition. Oncol. Lett. 2019;17:3017\u20133025. doi: 10.3892/ol.2019.9903.", "ArticleIdList": ["10.3892/ol.2019.9903", "PMC6365977", "30854080"]}, {"Citation": "Gao X., Liu Y., Deeb D., Arbab A.S., Gautam S.C. Anticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-\u03baB/mTOR signaling. J. Exp. Ther. Oncol. 2014;10:275\u2013283.", "ArticleIdList": ["PMC4268656", "25509983"]}, {"Citation": "Cuvillier O., Ader I. Hypoxia-inducible factors and sphingosine 1-phosphate signaling. Anti-Cancer Agents Med. Chem. 2011;11:854\u2013862. doi: 10.2174/187152011797655050.", "ArticleIdList": ["10.2174/187152011797655050", "21707486"]}, {"Citation": "Yang H., Landis-Piwowar K.R., Lu D., Yuan P., Li L., Reddy G.P., Yuan X., Dou Q.P. Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells. J. Cell. Biochem. 2008;103:234\u2013244. doi: 10.1002/jcb.21399.", "ArticleIdList": ["10.1002/jcb.21399", "17541980"]}, {"Citation": "Wei X., Zeng W., Xie K., Diao P., Tang P. Potential use of chymotrypsin-like proteasomal activity as a biomarker for prostate cancer. Oncol. Lett. 2018;15:5149\u20135154. doi: 10.3892/ol.2018.7936.", "ArticleIdList": ["10.3892/ol.2018.7936", "PMC5840742", "29552150"]}, {"Citation": "Tong L., Nanjundaiah S.M., Venkatesha S.H., Astry B., Yu H., Moudgil K.D. Pristimerin, a naturally occurring triterpenoid, protects against autoimmune arthritis by modulating the cellular and soluble immune mediators of inflammation and tissue damage. Clin. Immunol. 2014;155:220\u2013230. doi: 10.1016/j.clim.2014.09.014.", "ArticleIdList": ["10.1016/j.clim.2014.09.014", "PMC8136150", "25308129"]}, {"Citation": "Kim H.J., Park G.M., Kim J.K. Anti-inflammatory effect of pristimerin on lipopolysaccharide-induced inflammatory responses in murine macrophages. Arch. Pharmacal Res. 2013;36:495\u2013500. doi: 10.1007/s12272-013-0054-1.", "ArticleIdList": ["10.1007/s12272-013-0054-1", "23435916"]}]}], "History": [{"Year": "2020", "Month": "2", "Day": "29"}, {"Year": "2020", "Month": "3", "Day": "26"}, {"Year": "2020", "Month": "3", "Day": "27"}, {"Year": "2020", "Month": "4", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["32235333", "PMC7181184", "10.3390/molecules25071567", "molecules25071567"]}}]}